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Cardiovascular disease (CVD) causes the most deaths in the United States and is 
disproportionately impacting certain groups more than others.  A gap in the research 
exists when focusing on national data for those who bear the highest burden of CVD 
amongst people with hypertension when cardiovascular morbidity and mortality are 
examined. There is also a need to investigate the relationships between key indicators for 
CVD health disparities in people with hypertension. The purpose of this quantitative 
study is to investigate the cumulative effect of key health disparities indicators such as 
race, age, gender, education, and income using national-level surveillance data to 
determine if there are significant differences in CVD morbidity and mortality outcomes 
among people with hypertension. Systems theory is the theoretical foundation for this 
research study.  Two major research questions seek to determine if there are significant 
differences in the selected CVD morbidity and CVD mortality outcomes in hypertensive 
subpopulations who are ages 30 years and older who experience health disparities, and 
the best group in the United States for hypertension when 3 or more of the health 
disparities indicators intersect.  Data were provided by NHANES between 1999–2010.  
The results of multivariate analysis show that there are significant differences among 
people with hypertension in morbidity and mortality CVD outcomes when three or more 
health disparity indicators intersect.  Positive social change can result when the findings 
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Chapter 1: Introduction to the Study  
Introduction 
Cardiovascular disease (CVD) is the leading cause of death in the United States 
(Guide to Community Preventive Services, 2014).  It is estimated that a person in the 
United States suffers from a heart attack every 43 seconds (CDC, 2016). There are known 
risk factors for CVD (i.e., high cholesterol, smoking, and hypertension).  Hypertension or 
high blood pressure is a major risk factor for CVD that is often uncontrolled and 
undetectable (Valderama, Gillespie, Coleman King, et al., 2012). There are certain 
subpopulations in the United States who are disproportionately impacted by both CVD 
and hypertension resulting in major health disparities (CDC, 2013).   
Education, race and/or ethnicity, income, gender, and geographic location are 
used to determine subpopulations in the United States who often bear the highest burden 
of disease (Kreiger & Sydney, 1996; Liao, et al., 2011; and Opara, et al., 2013).  These 
subpopulations are experiencing health disparities that often lead to health inequities.  For 
example, Gupta (2011) conducted a study in Delaware and examined the prevalence of 
multiple risk factors for CVD and found that a higher proportion of those from population 
subgroups identified by socioeconomic status had multiple risk factors for heart disease 
and stroke.  The researcher found that prevalence of multiple risk factors was higher for 
those who were older, less educated, and unemployed (Gupta, 2011).  In another study by 
Zimmerman and Anderson (2019), the researchers utilized the Behavioral Risk Factor 
Surveillance System to determine if health equity has improved over the past 25 years 
from 1993 to 2017 among adults in the United States.  The researchers found a decline in 
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health equity and health justice over time, as well as worse income disparities 
(Zimmerman & Anderson, 2019). There are also examples of health disparities that are 
linked to geographic location.  O’Connor and Wellenius (2012) utilized data from the 
Centers for Disease Control and Prevention (CDC) 2008 Behavioral Risk Factor 
Surveillance System (BRFSS) to link health disparities to geographic location and they 
found that the crude prevalence rate of coronary heart disease was higher among those 
living in rural areas versus urban areas.   
  The purpose of my research study is to investigate the cumulative effect of key 
health disparities indicators such as race, age, gender, education, and income using 
national-level surveillance data to determine if there are significant differences in CVD 
morbidity and mortality outcomes among people with hypertension . Systems theory is 
the theoretical foundation.  There are two research questions related to morbidity and 
mortality of CVD among people with hypertension.  They seek to determine if there are 
significant differences in the selected CVD morbidity and CVD mortality outcomes in 
persons who are ages 30 years and older who experience health disparities, and the best 
group in the United States for hypertension, when 3 or more of the health disparities 
indicators intersect.  
This research study has the following potential positive social change 
implications.  First, I found few studies in the literature review that applied a health 
equity lens to national-level hypertension and CVD surveillance data to highlight health 
disparities.  Next, the findings from this study will fill a gap in the research as it relates to 
the impact of multiple risk factors for health disparities on the CVD health outcomes 
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among persons with hypertension.  According to Agurs-Collins, et al. (2019), who 
examined the impact of multilevel interventions to reduce health disparities, interventions 
that focus on only single or individual-level factors are limited in their impact.  The 
current study will contribute to the knowledge base in public health and clinical practice 
by highlighting the need to consider the cumulative effect of multiple health disparities 
indicators on those with hypertension when planning and implementing interventions. 
The major sections that will be covered in this chapter are the introduction, 
statement of the problem, purpose of the study, research questions and hypotheses, 
definitions of theoretical constructs, definition of terms, significance, assumptions and 
limitations, and summary. 
Background 
Numerous state- and local-level research studies have been conducted to examine 
the prevalence of cardiovascular diseases, as well as hypertension, and the associated risk 
factors on the state and local levels (Andersen & Jensen, 2013; Liao, et al., 2011).  
However, there is a gap in the research related to the impact of three or more 
demographic characteristics associated with health disparities on the CVD health 
outcomes among persons with hypertension.  Race, gender, education, age and income 
are the key demographic characteristics which are risk factors that are associated with 
CVD-related health disparities. 
Hypertension   
During my review of the hypertension literature, I found few studies that applied a 
health equity lens to national level hypertension data, compared it with cardiovascular 
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morbidity and mortality data, and examined the cumulative effect of multiple health 
disparities indicators on individuals with hypertension.  Hypertension has been found to 
disproportionately affect certain subpopulations.  In one example publication, the 
researchers examined racial/ethnic disparities in awareness, treatment, and control of high 
blood pressure by hypertension stages using the National Health and Nutrition 
Examination Survey (NHANES) during the period of 2003-2010 (Valderama, et al., 
2012). The researchers found that the proportion of Mexican-Americans and Blacks with 
Stage 1 and Stage 2 hypertension was greater than for Whites.  Stage 1 hypertension is 
140–159 systolic or 90–99 diastolic and Stage 2 hypertension is 160 or higher systolic or 
100 or higher diastolic (National Heart, Lung and Blood Institute, 2012).  However, the 
researchers made no efforts to further examine the health inequities that were identified 
in the study.  A similar study is needed for the impact of hypertension on CVD health 
outcomes.  
Loustalot, et al. (2014) also conducted a study in which they examined race.  
They found that mortality rates for hypertensive heart disease among Blacks were 
significantly higher than Whites in 2010 (50.9 per 100,000) when they examined the 
trends in mortality by subtypes of heart disease in the United States.  The Framingham 
study was the first major observational study that included substantial numbers of 
women.  It has also been central to the development of the notion of absolute risk and the 
importance of blood pressure alongside other risk factors (Turnbull, 2010).   
Hypertension is a major cause of disparities in mortality between Blacks and 
Whites in the United States because of the differences in prevalence and in hypertension 
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control (Opara, et al., 2013; Satcher, 2008;).  Hypertension disproportionately impacts 
some groups’ burden of cardiovascular disease more than others by beginning earlier in 
life and being more difficult to control.  For example, a 2018 study found that the 
cumulative incidence of hypertension by the age 55 years was 75.5% in Black men, 
75.7% in Black women compared to 54.5% White men, and 40.0% in White women 
(Thomas, et al., 2018). In addition to race, gender was found to be linked to disparities in 
hypertension in the literature.  For example, using a cohort study, Ford (2011) sought to 
examine the change in the all-cause mortality rate among people with and without 
hypertension in the United States and whether any such changes differed by gender or 
race.  The researcher found that the mortality rate was higher among hypertensive adults 
than non-hypertensive adults, among hypertensive men than hypertensive women, and 
among hypertensive Blacks than hypertensive Whites (Ford, 2011).     
CVD. All heart disease, coronary heart disease, acute myocardial infarction, and 
cardiac dysrhythmia are the CVD morbidity and mortality health outcomes for the 
research study.  Race has been found to have a negative impact on CVD outcomes and 
risk factors among certain subpopulations in the United States.  For example, Liu, et al., 
(2011) found that Hispanics and non-Hispanic Blacks were more likely to have 
uncontrolled blood pressure (BP; Hispanics odds ratio [OR]: 1.58, 95% confidence 
interval [CI]: 1.21-2.07; Blacks OR: 1.42, 95% CI: 0.21-1.67) and elevated glycosylated 
hemoglobin (Hispanics OR: 2.70, 95% CI: 1.89-3.87; Blacks OR: 2.17, 95% CI: 1.70-
2.77). The literature was reviewed to investigate the impact of age as a risk factor for 
CVD and hypertension.  A recent study by Gupta (2014) analyzed multiple risk factors as 
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well as self-reported CVD prevalence overall and discussed the differences in prevalence 
by age.  The prevalence of multiple risk factors was higher for the aged, less educated, 
and unemployed (Gupta, 2014). 
A review of the literature associated with the impact of education on hypertension 
and CVD was conducted.  There has been a long-standing inverse relationship between 
education and mortality that has strengthened substantially at the end of the 20th century 
(Cutler, et al., 2011).  A cross sectional study using the 2006 BRFSS to investigate 
education was conducted (Kelly & Weitzen, 2010).  After adjusting for confounders, 
respondents with less than a high school education had 1.61 (95% CI: 1.41-1.83) times 
the odds of having had an MI compared to college graduates.  According to the 
researchers’ findings, participants with a high school education and those who completed 
some college or technical school were 1.22 times more likely to have had a myocardial 
infarction in comparison to college graduates (Kelly & Weitzen, 2010).   
The relationships between income and hypertension, as well as CVD, were 
reviewed in the literature.  The ability to obtain health insurance in the United States is 
more commonly linked to the ability to have a source of employment that provides health 
care coverage.  One major research study found that: (a) the prevalence of hypertension 
and elevated LDL cholesterol was similar for the insured and uninsured, (b) the 
proportion of those who obtained treatment and achieved control of these risk factors was 
lower among the uninsured, and (c) uninsured men and women were less likely to be 
treated for hypertension (Brooks, et al., 2010). 
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There were specific subpopulations (i.e., non-Hispanic Blacks, low income, and 
low education) who were the most impacted when I examined the indicators (Ritchey, et 
al., 2014; Ford, 2011).  Additionally, I found that there were few research studies that 
examined CVD and hypertension on the national level.  In these studies, the researchers 
examined some of the indicators also (Liao, et al., 2012; Ritchey et al., 2014).  However, 
I did not find any recent studies that examined the cumulative effect of the health 
disparities indicators for CVD among people with hypertension on a national level. 
Problem Statement 
According to the CDC (2013), hypertension is a leading cause of CVD.  Both 
CVD and hypertension are disproportionately impacting certain subpopulations in the 
United States, resulting in major health disparities (CDC, 2013).  I found very few studies 
that applied a health equity lens to national level data amongst people with hypertension, 
compared it with cardiovascular morbidity and mortality, and investigated the relations 
between numerous indicators for health disparities.  The application of a health equity 
lens (or focusing first on those who bear the highest burden of the disease) is a new 
concept.  The health equity lens has not been widely written about and no formal 
definition currently exists for it.   
A gap exists in the literature as it relates to the analysis of national CVD event 
data for populations who are bearing the highest burden of the CVD by culture, 
socioeconomic status, and geographic region (Schieb, et al., 2013). Sentinel observational 
studies such as the Framingham Study, as well as other landmark observational studies, 
have played key roles in establishing the link between hypertension and many 
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cardiovascular diseases (Turnbull, et al., 2010).  The link between hypertension and CVD 
is created by demonstrating that the association between high blood pressure readings and 
cardiovascular risk was continuous, linear, and consistent across different age groups and 
for a range of major cardiovascular events (Lalonde, et al., 2012).  The Framingham 
study was integral in the development of the concept of absolute risk and the importance 
of blood pressure alongside other risk factors (Turnbull, et al. 2010).  There were other 
important studies such as Ritchey, et al.’s (2014) investigation of the mortality trends in 
heart disease that established the foundation for much of this research.  I was able to find 
numerous examples of recent CVD morbidity and mortality literature, such as the study 
by Yang, et al. (2015) in which the researchers examined the racial, sociodemographic, 
and state-level disparities in heart age among U.S. adults who are 30 years and older.  
Schieb, et al. (2013) described the disproportionate number of death rates from heart 
disease, stroke, and hypertensive disease related to race and geographic location in the 
United States.  
In this study, I have expanded the literature by investigating numerous health 
disparities indicators for CVD among people with hypertension and examining the 
cumulative effect of three or more health disparities indicators.  There were previous 
studies that had similar foci.  For example, data from the Multiple Cause of Death Files 
during 1999-2013 were compiled from 57 vital statistics jurisdictions (CDC, 2015).  
When gender and age were examined, the researchers reported that the average annual 
rate of first CVD events rises from three per 1,000 men at 35-44 years-old to 74 per 1,000 
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men at 85-94 years-old with comparable rates found to occur 10 years later in life among 
women (CDC, 2015).     
Purpose of the Study 
In this quantitative cross-sectional study, I utilized national surveillance data to 
explore the cumulative effect of demographic characteristics such as race, gender, age, 
education, and income to determine if there are significant differences in CVD morbidity 
and mortality outcomes among hypertensive subpopulations that are linked to CVD and 
hypertension health disparities.  A hypertensive subpopulation is defined in the following 
three ways: (a) an average systolic blood pressure (SBP) ≥140 mmHg;, (b) an average 
diastolic blood pressure (DBP) ≥90 mmHg, or (c) currently using blood pressure 
lowering medication (Valderama, et al., 2010).  The independent variables for the 
research study were education level, age, household income, race/ethnicity, body mass 
index (BMI), and gender.  The dependent variables were CVD morbidity – 
hospitalizations for pain or discomfort in the chest and coronary heart disease, acute 
myocardial infarction, heart failure and cardiac dysrhythmia diagnoses.  CVD mortality – 
death as a result of coronary heart disease, acute myocardial infarction, heart failure and 
cardiac dysrhythmia diagnoses.  Covariate variables that were also considered are 
smoking, cholesterol levels, and hemoglobin A1-C levels.   
Research Questions and Hypotheses 
  I examined the following research questions and hypotheses in this research 
study.   
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Research Question 1 (RQ1): Are there significant differences in the selected CVD 
morbidity outcomes between hypertensive subpopulations, adults who are 30 years and 
older, experiencing health disparities and the best group (i.e., the subpopulation with the 
best CVD morbidity outcomes) in the United States for hypertension and when three or 
more indicators (race, gender, education, age and income) intersect?  The following 
variables that are relevant include: CVD morbidity as a dependent variable; education 
level, household income, race/ethnicity, body mass index (BMI), and gender are the 
independent variables.  Other covariates are hypertension medications, taking 
cardiovascular medications, smoking, and cardiovascular fitness.   
Null Hypothesis (H01):  There are no significant differences in the selected CVD 
morbidity outcomes between hypertensive subpopulations experiencing health disparities 
and the best group with hypertension in the United States when three or more indicators 
intersect. 
Alternative Hypothesis (Ha1): There are significant differences in the selected 
CVD morbidity outcomes between hypertensive subpopulations experiencing health 
disparities and the best group with hypertension in the United States when three or more 
indicators intersect. 
Research Question 2 (RQ2): What are the significant differences in CVD 
mortality outcomes between hypertensive subpopulations experiencing health disparities 
and the best group (i.e., the subpopulation with the best CVD mortality outcomes) with 
hypertension in the United States when three or more indicators (race, gender, education, 
age and income) intersect?  The following variables that are relevant to this question 
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include: CVD mortality as a dependent variable; education level, household income, 
race/ethnicity, BMI, and gender are the independent variables.  Other covariates are 
hypertension medications, taking cardiovascular medications, smoking, and 
cardiovascular fitness.  
Null Hypothesis (H02):  There are no significant differences in CVD mortality 
outcomes between hypertensive subpopulations experiencing health disparities and the 
best group with hypertension in the United States when three or more indicators intersect. 
Alternative Hypothesis (Ha2): There are significant differences in CVD mortality 
outcomes between hypertensive subpopulations experiencing health disparities and the 
best group with hypertension in the United States when three or more indicators intersect.   
Theoretical and Conceptual Framework for the Study 
I used systems theory as the theoretical framework for this cross-sectional 
observational study.  Systems theory originated from the notion that the interrelations of 
multiple perspectives from complex systems should be taken into consideration in public 
health (Leischow & Milstein, 2006).  The ability to simultaneously explore these 
connections among different components and among different subareas on the macro- 
level is a major focus of systems theory.      
My emphasis in this study on the cumulative effect of indicators for health 
disparities is in alignment with systems theory’s focus on the inter-relations of multiple 
components.  I used systems theory in this study’s macro-level focus on CVD outcomes 
among people with hypertension across the United States by examining the impact of 
numerous health disparities indicators on CVD morbidity and mortality.  The reliance on 
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simulation (or modeling in order to examine relationships) and numerous variables are 
key components of this theory that align with the approach and research questions of this 
study.  A more detailed explanation of Systems theory and its relation to the research  
study will follow in Chapter 2.   
In this research study, I sought to determine if relationships exists between 
numerous selected components or indicators using the principles contained in systems 
theory for a large study population to determine if there are significant differences in 
CVD morbidity and mortality outcomes among hypertensive subpopulations 
experiencing health disparities in comparison to people with hypertension who do not 
experience health disparities.  The intersectionality of multiple health disparities 
indicators (i.e., race, gender, age, education, and income) amongst hypertensive 
subpopulations can also be examined using this method.  In systems theory, Leischow 
and Milstein (2005) described the emphasis on relationships and the desire to obtain a 
larger, more connected understanding are critical to this study.       
Traditionally, cardiovascular and hypertension morbidity and mortality data are 
examined based on each of the indicators individually.  According to the Guide for 
Community Preventive Services (2015), nearly half of Americans show at least one of 
three key CVD risk factors which are hypertension, uncontrolled high levels of low-
density lipoprotein cholesterol (LDL), and smoking.  LDL and smoking are covariates 
while hypertension is the major focus for this study.  Uncontrolled hypertension is a 
major concern for many of the persons with hypertension.  One national study of 36 
million U.S. adults found that approximately 39% were unaware of the fact that they are 
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hypertensive, 16% knew about their hypertensive status but were not on medication, and 
45% were taking medicine but did not have their blood pressure under control 
(Valderama, Gillespie, et al., 2012).  There are demographic factors that must be 
considered in order to explain why certain subpopulations are struggling to control their 
hypertension, and thus prevent morbidity and mortality associated with CVD.  By 
preemptively considering the demographic and epidemiologic findings to prioritize those 
who were identified as being disproportionately impacted by hypertension, I applied a 
health equity lens to this research study.  In this quantitative study, I incorporated a health 
equity lens and systems theory into its approach in order to address these issues.  The 
connections among these key elements will be examined in more detail in Chapter 2.    
Nature of the Study 
The nature of this research study was quantitative and I used a cross-sectional 
design. I used quantitative data that has been previously collected over a period of 4 years 
from a large sample of study participants to rigorously analyze data in a timely manner 
from a national surveillance study.  I used CVD event surveillance data and secondary 
data analysis to respond to the research questions.  The key study variables included: 
dependent variables such as CVD morbidity and mortality variables.  Independent 
variables were: education level, household income, race/ethnicity, body mass index 
(BMI), and gender.  Having hypertension was an inclusion criterion for this study.  Other 
covariates were: hypertension medications, taking cardiovascular medications, smoking, 
and cardiovascular fitness.   
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I analyzed secondary data from previously collected data that was derived from a 
sample of the National Health and Nutrition Survey (NHANES) 1999-2010 participants 
to explore potential differences in health outcomes among subpopulations with 
hypertension.  These participants may have had varying indicators for health disparities.  
I analyzed the data using SAS to perform the following analyses: descriptive statistics, 
bivariate analysis, multivariate analysis, and regression modeling.   
Definitions 
Covariates: Are “any of two or more random variables exhibiting correlated 
variation” (Merriam-Webster, 2016).  Smoking, elevated cholesterol and obesity are 
examples of covariates.  
Dependent Variables:  “A mathematical variable whose value is determined by 
that of one or more other variables in a function” (Merriam-Webster, 2016).  Dependent 
variables in the research study may include coronary heart disease, acute myocardial 
infarction, and cardiac dysrhythmia. 
Health Disparity: “a particular type of difference in health (or in the determinants 
of health that could be shaped by policies) in which disadvantaged social groups 
systematically experience worse health or more health risks than do more advantaged 
social groups” (Braverman, 2009).   
Health Equity: “the absence of avoidable or remediable differences among groups 
of people, whether those groups are defined socially, economically, demographically, or 
geographically” (World Health Organization, 2015).  
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Health Equity Lens: The application of a health equity lens is a new concept that 
has not been widely written about and no formal definition currently exists.  A health 
equity lens is applied when the researcher or practitioner proactively analyzes the 
epidemiological findings to implement interventions and/or conduct research that 
prioritizes those who were identified as being disproportionately impacted by a disease.   
Hypertension: A person is considered to have hypertension in one of the 
following three ways: 1) an average systolic blood pressure (SBP) ≥140 mmHg; or 2) an 
average diastolic blood pressure (DBP) ≥90 mmHg; or 3) currently using blood pressure 
lowering medication (Valderama, et al., 2010). 
Independent Variables:  “A mathematical variable that is independent of the other 
variables in an expression or function and whose value determines one or more of the 
values of the other variables” (Merriam-Webster, 2016).  Examples of independent 
variables are the demographics in the research study. 
Systems Theory: “an interdisciplinary theory that requires merging of multiple 
perspectives and sources of information and deals with complex systems in technology, 
society, and science” (Best, et al., 2003). 
Assumptions 
I made the aassumptions by and about subpopulations with hypertension.  The 
following misconceptions among hypertensive populations are discussed below.  
Contracting high blood pressure is assumed to be inevitable amongst some people with 
hypertension.  There is a belief that a hypertension diagnosis can only be treated and 
controlled by medication.  Because hypertension often has no symptoms, then treatment 
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is not a priority.  Some persons with hypertension believe that there is no cure for 
hypertension.  Some medical providers believe that the non-compliance to medication of 
certain subpopulations related to hypertension and CVDs cannot be helped.  This is a 
major misconception that exists among some providers. 
These assumptions are important to keep in mind because many of them are held 
by the subpopulations who are disproportionately impacted.  The finding from the 
research study can raise the awareness of the populations by addressing these 
misconceptions.  These assumptions may assist in building the case for applying a health 
equity lens to interventions and addressing the social determinants of health by providers 
and public health practitioners that are associated with hypertension and CVDs.  
According to the Office of Disease Prevention and Health Promotion (2020), “social 
determinants of health reflect the social factors and physical conditions structural 
conditions in which people are born, live, learn, work, worship, play, and age” 
(Paragraph 6).  These are recognized as critical determinants of health and health 
disparities.    
 
Scope and Delimitations 
There is a drastic need to address the multiple risk factors related to CVD health 
outcomes that disproportionately impact certain hypertensive subpopulations in the 
United States.  The specific aspects of this research problem will be addressed in this 
research study.  They include: demographic indicators such as race, gender, age, 
education, and income; CVD health outcomes (i.e., morbidity and mortality); 
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hypertension as a major risk factor; and the cumulative effect of the indicators of CVD 
among people with hypertension on a national level. 
The populations who are included in the research study are large samples from the 
United States population that were extracted from the NHANES survey.  Adult 
respondents from all races and ethnicities that are 30 years and older who were diagnosed 
with hypertension were sampled.  Individuals who were not diagnosed with hypertension 
and were younger than 30 years-old were excluded.  In addition to age, the sample will be 
further categorized by education, gender, race or ethnicity, and income.   
There were theories and concepts such as the Social Ecological Model and 
empowerment that are relevant to this study but were excluded because a broader 
approach was needed.  The Social-Ecological model is a multi-level approach that 
considers the different domains of influence and provides an overarching framework for 
understanding the interrelations among diverse personal and environmental factors 
(Fleury & Lee, 2006).  This model spans across the following categories: intrapersonal 
resources, interpersonal resources, and community and environmental resources (Fleury 
& Lee, 2006).  Empowerment is defined as “a social action process for people to gain 
mastery over their lives and the lives of their communities” (Batholomew, et al., 2011, 
p.1).  It is important to ensure that the needs of all sub-groups are met when the 
populations are diverse.  Empowerment provides a means for those sub-groups who have 
been marginalized to regain a sense of control and awareness of their health outcomes in 
health promotion.  Additionally, the findings from this study can be generalized to 
persons in the general United States population who are either hypertensive, or at-risk for 
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hypertension and CVD.  The sample size is large enough to be applicable on the micro, 
meso, and macro levels.  It also allows practitioners to translation the research findings to 
practice.              
Limitations 
This correlational study focused on the relationships between the demographic 
variables related to health disparities, hypertension and CVD.  Causation cannot be 
assessed for studies of this type.  Internal validity is weaker for correlational than for 
experimental designs.  The health interview portion of the data collection relies on the 
participant to remember specific events.  Difficulty with memory among the participants 
is a limitation with cross sectional studies of this type.  This may result in inaccurate or 
biased recall.   
The ability to recall the sequence of events can pose a problem.  There are also 
confounder variables, such as smoking, that may influence CVD outcomes which were 
not examined in this research study.  This did not significantly impact the results of this 
study because many of the confounders such as smoking are not as closely linked to 
hypertension, which is an inclusion criterion for this study.  According to the American 
Heart Association (2016), the connection between smoking and hypertension is still being 
determined.  This study employed multivariate analysis and regression analysis to 
determine the direction of the relationship between variables.  For the purposes of this 
study, a correlational design was appropriate despite its limitations because the intention 




This research study can potentially contribute to the scientific evidence-base by 
identifying and describing national cardiovascular and hypertension health disparities 
using specified indicators (i.e., race and/or ethnicity, education, income, gender, and age) 
among individuals within certain subpopulations in the United States.  The following 
CVD evidence gaps that were identified by the Community Preventive Services Task 
Force were explored in this study: large scale studies; more diverse populations; 
information on socioeconomic status (SES); and reporting of morbidity and mortality 
outcomes (Guide to Community Preventive Services, 2012).  This study helps to fill the 
large scale studies gap by including a much larger sample from a national-level data 
source.  The need for more diverse populations and SES information was met in this 
study because of its emphasis on examining CVD and hypertension data from 
subpopulations who are from diverse races and/or ethnicities, education levels, and 
incomes.  This study examined the socioeconomic and demographic information from 
national data of subpopulations who are the most at-risk for CVD.  By focusing on the 
cumulative effect of the major risk factors, this study expands the knowledge base by 
identifying those variables that converge to place certain persons with hypertension at an 
increased risk for morbidity and mortality related to CVD.  The findings from this study 
informed efforts such as policies, interventions, and resources allocated to reduce 
cardiovascular events and hypertension health disparities by clinical and public health 
practitioners.   
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This study has the potential to contribute to positive social change by highlighting 
the CVD and hypertension-related health disparities that are faced by those who are 
commonly under-resourced, under-represented, and marginalized.  The inclusion of 
systems theory promotes the “big picture perspective” and results in a more diverse 
approach to collaboration and data collection.  Organizations from academia, medicine, 
and public health could form better collaborations.  It would also lead to gathering and 
analyzing different types of data (i.e., behavioral and environmental) and integrating that 
data and interpreting it.  It will also assist researchers and practitioners in their efforts to 
understand those subpopulations who bear the highest burden of CVD events and 
hypertension in the United States by applying a health equity lens, as well as 
implementing tailored approaches. 
Summary 
Chapter 1 discussed the need to analyze national CVD event data for hypertensive 
subpopulations in the United States who are bearing the highest burden of CVD 
morbidity and mortality.  The cumulative effect of those risk factors that are linked to 
health disparities among those people with hypertension who are most at risk for CVD 
morbidity and mortality is an important component of this research study that was 
described.  The purpose of the study, research questions, hypotheses, definitions, 
significance, scope, limitations, and significance were also examined.  For the indicators 
in certain subpopulations, I found that morbidity and mortality health disparities existed 
for CVD and hypertension.   
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Chapter 2 provides a detailed review of the existing literature associated with 
CVD outcomes among people with hypertension in the United States who are at 
increased risk.  The chapter will begin with literature associated with the theoretical basis 
for the research study. Systems theory is the theoretical basis for this study.  
Cardiovascular diseases, hypertension, health disparities, health equity, geographic 
location, race, age, gender, education, and income, will be further examined in the 
literature review.  The sections of this literature review include: the Introduction, 
Literature Search Strategy, Theoretical Foundation, Literature Review Related to Key 
Variables and/or Concepts, Implications of Past Research on Present Research, and the 





Chapter 2: Literature Review 
Introduction 
In this literature review, I discuss the need for continued research concerning the 
cumulative effect of indicators (i.e., race, gender, education, income, and geographic 
location) within certain subpopulations that lead to CVD morbidity and mortality 
associated with hypertension in the United States.  In this quantitative study, 
subpopulations refer to the persons from the national samples or demographic groups 
when the population data of the United States is disaggregated.  CVD health disparities 
have been among the most serious public health problems in the United States (Mensah, 
2005).  According to the American Heart Association (2011), CVD morbidity can include 
numerous heart problems such as strokes, heart failure, arrhythmia, and heart attacks.  
Cardiovascular mortality is defined as deaths among people with an underlying cause of 
ischemic heart disease from the following International Classification of Diseases, 10th 
Revision (ICD-10) codes: cerebrovascular disease (stroke) (I60–I69), hypertensive 
disease (I10–I15), or chronic rheumatic heart disease (I05–I09; Macinko & Elo, 2009).  
In this study, I focused on cerebrovascular disease (stroke), hypertension, and chronic 
rheumatic heart failure among adults who are 30 years and older.   
The purpose of this quantitative study was to investigate the cumulative effect of 
indicators (i.e., age, race, gender, education, and income) using surveillance data from 
across the United States to determine if there are significant differences in CVD 
morbidity and mortality outcomes among hypertensive subpopulations that are linked to 
CVD and hypertension health disparities.  A health disparity is defined as “a particular 
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type of difference in health (or in the determinants of health that could be shaped by 
policies) in which disadvantaged social groups systematically experience worse health or 
more health risks than do more advantaged social groups” (Braverman, 2009, p. A91).  
There are widening CVD health disparities detected across the United States over the past 
30 years in population subgroups identified by race, ethnicity, gender, socioeconomic 
status, educational level, and geography (Mensah, 2005). 
There is a link between hypertension and the risk of many cardiovascular 
diseases.  Sentinel observational studies such as the Framingham Study, as well as other 
landmark observational studies, have been instrumental in examining this relationship by 
demonstrating that the association between blood pressure and cardiovascular risk was 
continuous, linear, and consistent across different age groups and for a range of major 
cardiovascular events (Lalonde, et al., 2012).  The Framingham study has played an 
important role in the development of the notion of absolute risk and the importance of 
blood pressure alongside other risk factors (Turnbull, et al. 2010).  In addition to the 
Framingham Study, there were other seminal studies such as Ritchey, et al.’s (2014) 
examination of the mortality trends in heart disease that established the foundation for 
much of this research.  Numerous examples of recent literature were also found, such as 
the study by Yang, et al. (2015), in which the researchers examined the racial, 
sociodemographic, and state-level disparities in heart age among U.S. adults who are 30 
years and older.  In another study by Schieb, et al. (2013), the researchers described the 
disproportionate number of death rates from heart disease, stroke, and hypertensive 
disease linked to race and geographic location in the United States.   
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In this review, I examined literature associated with systems theory, which is the 
theoretical basis for this study, as well as cardiovascular diseases, hypertension, health 
disparities, health equity, geographic location, race, age, gender, education, and income.  
The major sections of this chapter include: the Introduction, Literature Search Strategy, 
Theoretical Foundation, Literature Review Related to Key Variables and/or Concepts, 
Implications of Past Research on Present Research, and the Summary.     
Literature Search Strategy 
To search the literature, I used three databases and search engines as the primary 
resources of information.  The scope of the literature review spanned from 2005 to 2019.  
I searched peer-reviewed journal articles, literature reviews, book chapters, and 
commentaries. Medline was a major source of biomedicine and life sciences journals.  
PubMed is a larger database with biomedical literature from MEDLINE, life science 
journals, and online books.  I also used CINAHL to search for journals from the fields of 
nursing and allied health.  The citations for all literature used was stored in the 
EndNoteX7 reference library.  
To perform the literature review, the independent variables (race, gender, 
education, income, and geographic regions of the United States) and dependent variables 
(cardiovascular disease morbidity, cardiovascular disease mortality, hypertension 
morbidity, and hypertension mortality) formed the basis of the key word search.  I 
utilized a specific search strategy using cardiovascular disease, hypertension, mortality, 
morbidity, United States, trends, surveillance, epidemiology, health disparities, ethnic 
disparities, racial disparities race, gender, education, income, geographic region, and 
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health inequities as key search terms to retrieve the relevant literature.  I used a variety of 
combinations when searching for the key words.  
Theoretical Foundation 
Systems Theory 
 I used systems theory as the theoretical framework for this cross-sectional 
observational study.  The origin of systems theory in public health is derived from the 
systems approach which is a paradigm that focuses on the interactions among different 
components versus a single element (Leischow & Milstein, 2006).  The Institute of 
Medicine made key recommendations regarding systems approaches in a 2010 report 
from (For the Public’s Health: The Role of Measurement in Action and Accountability) 
to improve health data analysis and reporting (Yang, et al., 2015).  According to 
Leischow and Milstein (2006), being aware of the wider context and transdisciplinary 
thinking are also important in the systems approach (Leischow and Milstein, 2006).  In 
addition to transdisciplinary thinking, the ability to take multiple perspectives from 
complex systems is also needed.  Systems theory is defined as “an interdisciplinary 
theory that requires merging of multiple perspectives and sources of information and 
deals with complex systems in technology, society, and science” (Best, et al., 2003. p. 
S207). 
This study’s emphasis on the cumulative effect of indicators for health disparities 
is in alignment with Systems theory’s focus on multiple components.  For example, 
Systems theory’s particular emphasis on multiple variables can be transferred to the 
indicators for health disparities in this study.  The states, as well as regions of the United 
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States, and the hypertensive subpopulations that are impacted by the indicators for health 
disparities make up the system in this study.  According to Lehrer and Eddie (2013), a 
system is defined as a variety of elements that interact with one another to form a whole 
entity.  The unique parts or elements are not separated from each other and the 
characteristics of the whole entity cannot generally be inferred from characteristics of its 
components (Lehrer and Eddie, 2013).  There are two major theoretical propositions that 
are appropriate to the application of Systems theory in this study.  Its reliance on 
simulation and numerous variables are the two propositions. According to Green (2006), 
systems theory relies on simulation rather than the controlled trial as the major source of 
evidence.  Additionally, it treats numerous variables as a resource to be used for further 
evaluation than as adversaries to be controlled.  The intent of this study is to analyze 
multiple indicators and to generalize from large samples to the U.S. population.  Green 
(2006) stated that systems science can “help us unravel the complexity of causal forces in 
our varied populations and the ecologically layered community and societal 
circumstances of public health practice” (p. 406).  
It is important to ensure that Systems theory is related to the study’s research 
questions.  The research questions for this research study will test the cumulative effect 
of several indicators that lead to CVD morbidity and mortality associated with 
hypertension in the United States.  Systems theory provides the organizing theoretical 
framework through which the indicators at different levels and of different domains can 
be explicitly integrated dynamically in understanding health disparities (Diez Roux, 
2011).  Additionally, Systems theory allows the synthesis of meaning from a broad 
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evidence base by simultaneously exploring relationships among different subareas (i.e., 
health disparities indicators, hypertension and cardiovascular disease) of the field being 
considered (Mabry, 2010).  Systems theory was utilizes for this study’s macro level focus 
on hypertension and cardiovascular disease across the United States by providing 
national level health disparities data and addressing the social determinants of health.  
Literature Review Related to Key Variables and Concepts 
Morbidity and Mortality of Cardiovascular Diseases and Hypertension 
There are numerous studies that highlight the impact of hypertension on certain 
subpopulations.  I utilized the research questions to examine whether significant 
differences exist in the selected CVD morbidity and mortality outcomes between 
hypertensive subpopulations who are experiencing health disparities among people with 
hypertension when three or more indicators (race, gender, education, income) intersect.  I 
reviewed the literature related to the research questions.  For example, in a research study 
by Loustalot, et al. (2014), the researchers examined the trends in mortality by subtypes 
of heart disease in the United States.  Loustalot, et al. (2014) found that mortality rates 
for hypertensive heart disease among Blacks were significantly higher than Whites in 
2010 (50.9 per 100,000).  The Framingham Study is a sentinel study in this literature 
review.  It was the first major observational study that included substantial numbers of 
women and it has been central to the development of the notion of absolute risk and the 
importance of hypertension alongside other risk factors (Turnbull, 2010).  Much of our 
current understanding of the role blood pressure in cardiovascular disease can be 




I reviewed the literature for hypertension and its relationship to CVD morbidity 
and mortality.  Hypertension impacts approximately 1 in 3 adults (an estimated 75 
million) in the United States (Fryar, et al., 2017).   I also reviewed hhypertension health 
disparities.  In a study by CDC (2005), the researchers analyzed self-reported data from 
the 2003 BRFSS survey. The CDC (2005) researchers examined six risk factors for heart 
disease and stroke: high blood pressure, high cholesterol, diabetes, current smoking, 
physical inactivity, and obesity.  In this study, 37.2% of respondents reported having two 
or more of the six heart disease and stroke risk factors examined (CDC, 2005). The CDC 
study is similar to this research study in its examination of multiple risk factors for CVD.  
However, to expand on the prior study, I analyzed the potential relationship between 
health disparity indicators and CVD.  
I reviewed the literature that specifically identified racial disparities in 
hypertension.  Hypertension is a major cause of disparities in mortality between Blacks 
and Whites in America because of the differences in prevalence and in hypertension 
control (Satcher, 2008; Opara, et al., 2013).  In another study, racial disparities in systolic 
blood pressure (SBP) measurements were analyzed among 1,545 Black adults and 1,335 
White adults (Fiscella & Holt, 2008).  The results of the study showed that the mean SBP 
among Blacks with hypertension was approximately 6 mm Hg higher than that for the 
total adult Black population and 7 mm Hg higher than that for Whites with hypertension.   
In addition to race, I identified other indicators (i.e., gender, education, income, 
and geographic location) that are linked to disparities in hypertension and evaluated in 
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the literature.  For example, in one cohort study, the researchers sought to examine the 
change in the all-cause mortality rate among people with and without hypertension in the 
United States and whether any such changes differed by sex or race (Ford, 2011).  The 
researcher found that the mortality rate was higher among hypertensive adults than non-
hypertensive adults, among hypertensive men than hypertensive women, and among 
hypertensive Blacks than hypertensive Whites (Ford, 2011).  I determined the prevalence 
of healthy diets in overweight U.S. adults by race or ethnicity by using dietary recalls 
from the National Health and Nutrition Examination Survey of 1999 to 2000.  After 
controlling for dietary factors, Black ethnicity was associated with a greater risk of high 
SBP compared to Whites (Diaz, et al., 2005).  This is an example of a national study that 
focuses on racial health disparities in hypertension.  However, in this study I go further 
by examining the cumulative effect of multiple health disparity indicators among people 
with hypertension. 
Impact of Geographic Location on CVD and Hypertension 
I reviewed the morbidity and mortality outcomes for CVD and hypertension by 
geographic location in the scientific literature.  A critical review of the literature revealed 
that there are certain areas in the United States that are more heavily impacted by health 
disparities than others.  Cosby and Bowser (2008) described the disparities associated 
with excess mortality in the Delta region of the United States The Delta region refers to 
the 252 economically distressed counties in the following eight states: Alabama, 
Arkansas, Illinois, Kentucky, Louisiana, Mississippi, Missouri, and Tennessee (National 
Park Service, 2001).   Cosby and Bowser (2008) found that mortality disparities in the 
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Delta had doubled to about 187 excess deaths per 100,000, or approximately 18,000 
excess deaths in 2004. Cosby and Bowser (2008) concluded that these deaths would not 
have occurred had the region achieved the average rate of mortality experienced by the 
remainder of the nation.   
Geographic location has been shown to play a factor in health outcomes related to 
heart disease and hypertension.  Schieb, et al. (2013) examined National Vital Statistics 
mortality data from 2001-2010 by race and gender in geographic regions of the United 
States The emphasis of the researchers was primarily on geographic regions, race and 
gender.   Schieb, et al. (2013) found that CVD mortality was disproportionately 
impacting Blacks and is located in the southern region of the United States.  Regarding 
gender, Black men experienced the most CVD deaths.  However, they did not include 
education and income as focus areas.   
In a study that relied on data from the BRFSS and the American Community 
Survey, Jones (2013) examined the impact of segregation and socioeconomic status 
(SES) on hypertension for a sample of 200,102 individuals (Jones, 2013). Jones (2013) 
analyses and findings revealed that both segregation and hypersegregation (i.e., areas 
where there is very little interaction with non-Black residents) were associated with 
hypertension.  However, highly educated and high-earning individuals were protected 
against hypertension in both segregated and hypersegregated environments (Jones, 2013). 
I compared rural and urban incidence of coronary heart disease.  O’Connor and 
Wellenius (2012) examined the rural-urban differences in the prevalence of diabetes and 
coronary heart disease, and the extent to which they are explained by the presence of 
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established risk factors including poverty.  The crude prevalence rates of coronary heart 
disease was 38.8% (P < 0.001) higher among respondents living in rural areas compared 
with urban areas (O’Connor & Wellenius, 2012).  After controlling for poverty, obesity, 
tobacco, and other risk factors, the prevalence of coronary heart disease was higher 
among respondents living in rural areas (O’Connor & Wellenius, 2012).  This research 
study expanded this area of research by using national data to analyze health disparity 
indicators in people with hypertension across regions and states of the U.S. 
Impact of Race on CVD and Hypertension 
CVD and race. Race has also been found to play a major role as a CVD risk 
factor among certain subpopulations.  For example, Liu, et al., (2011) investigated racial 
disparities and trends in glycosylated hemoglobin, high-density lipoprotein (HDL), C-
reactive protein, plasma homocysteine, albuminuria, and other risk factors among 4,758 
diagnosed hypertensive subjects age 18 years or older from the NHANES, 1999-2006.  
They found that Hispanics, and non-Hispanic Blacks were more likely to have 
uncontrolled blood pressure (BP) (Hispanics odds ratio [OR]: 1.58, 95% confidence 
interval [CI]: 1.21-2.07; Blacks OR: 1.42, 95% CI: 0.21-1.67), elevated glycosylated 
hemoglobin (Hispanics OR: 2.70, 95% CI: 1.89-3.87; Blacks OR: 2.17, 95% CI: 1.70-
2.77), albuminuria (Hispanics OR: 2.36, 95% CI: 1.71-3.27; Blacks OR: 1.80, 95% CI: 
1.47-2.20), and less likely to have central obesity (Hispanics OR: 0.68, 95% CI: 0.51-
0.91; Blacks OR: 0.70, 95% CI: 0.58-0.84). Blacks had lower risks of elevated serum 
cholesterol (OR: 0.81, 95% CI: 0.67-0.98) and low HDL (OR: 0.76, 95% CI: 0.61-0.94) 
than Whites. The risk of high serum homocysteine was lower in Hispanics and higher in 
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Blacks compared with Whites (Hispanics OR: 0.64, 95% CI: 0.46-0.90; Blacks OR: 1.36, 
95% CI: 1.14-1.63).  These findings are in alignment with other studies of this type that 
were reviewed.   
A study by Holm, et al., (2010) measured health disparities by comparing the 
American Indian sample data with a northern plains statewide (North Dakota) sample and 
a United States national sample. Holm, et al., (2010) compared outcomes with BRFSS 
statewide (North Dakota) and U.S. national data from telephone-based interviews.  The 
American Indian participants showed a significantly greater coronary heart disease than 
either the regional or national samples (Holm, et al., 2010). They also reported being less 
likely to engage in leisure-time physical activity and to have had age-appropriate 
preventive screenings for several diseases including colorectal cancer, prostate cancer, 
breast cancer, and cardiovascular disease. 
Hypertension and race. Race is a known population parameter and health 
indicator that is commonly associated with health disparities that has been studied in 
numerous creative ways.  A sentinel study of racial discrimination examined the 
relationships between blood pressure and self-reported experiences of racial 
discrimination and responses to unfair treatment (Kreiger & Sidney, 1996).  The 
researchers found that Black-White differences in blood pressure were substantially 
reduced by taking into account reported experiences of racial discrimination and 
responses to unfair treatment (Krieger & Sidney, 1996).   
Race can also play a factor in patient satisfaction.  The researchers in this study 
compared the determinants of satisfaction with medical care among 1,784 (781 Black and 
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1,003 Caucasian) cardiac patients (LaVeist, et al., 2000).  They found that the perception 
of racism and mistrust of the medical care system led to less satisfaction with care among 
Blacks (LaVeist, et al., 2000).  In a study that analyzed temporal trends in population 
attributable risk for CVD, the researchers studied 13,541 participants (56% women, 26% 
Black) in the Atherosclerosis Risk in Communities Study, aged 52 to 66 years and free of 
CVD at exams in 1987 through 1989, 1990 through 1992, 1993 through 1995, or 1996 
through 1998 (Cheng, et al., 2014).  It was determined from this study that the 
contribution to CVD of all traditional risk factors combined is greater in Blacks than 
Whites, and the contributions of hypertension remain especially high, in women as well 
as Blacks (Cheng, et al., 2014). 
This research study seeks to examine race by taking a national perspective and 
examining the cumulative effect of risk factors that are associated with CVD and 
hypertension health disparities.  Similar studies have been done which have analyzed 
national data and found health disparities.  An example of a study that spanned across 17 
states and 28 communities reinforces the need to further examine health disparities data 
from a national perspective.  In this study, Liao, et al. (2011) utilized data from the 
REACH U.S. Risk Factor Survey to demonstrate that residents in most of the minority 
communities continue to have lower socioeconomic status, greater barriers to health-care 
access, and greater risks for and burden of disease compared with the general populations 
living in the same MMSA, county, or state.  However, there are fewer studies that have 
analyzed the cumulative effect of racial health disparities indicators among people with 
hypertension and CVD. 
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In addition to Blacks and Hispanics, American Indian/Alaska Natives were also 
found to experience disparities in blood pressure when compared to Whites.  Amparo, et 
al., (2011) examined the prevalence of high cholesterol, high blood pressure, diabetes, 
body mass index data for 2,821 American Indian/Alaska Native women and 105,664 non-
Hispanic White women aged 18 to 44 years from the 2005 and 2007 Behavioral Risk 
Factor Surveillance System.  American Indian/Alaska Native women were found to have 
significantly higher rates of high blood pressure (Amparo, et al., 2011). 
There were studies identified that examined the intersection of race with other 
indicators of hypertension and CVD.  In one such study, the researchers evaluated the 
disparate association of BMI and risk of hypertension and diabetes in Asians in a 
retrospective study of 150,753 adults from the 1985-2011 California Behavioral Risk 
Factor Survey (Wong, et al., 2014).  Asians had the lowest BMI among all groups. 
However, the impact of increasing BMI on risk of hypertension and diabetes was 
significantly greater in Asians (Wong, et al., 2014).  To examine racial/ethnic disparities 
in awareness, treatment, and control of high blood pressure by hypertension stages, the 
Centers for Disease Control and Prevention (2013) analyzed data from the National 
Health and Nutrition Examination Survey (NHANES) for the period 2003-2010.  The 
researchers found that the proportion of Mexican-Americans and Blacks with stage 1 and 
stage 2 hypertension was greater than for Whites (Centers for Disease Control and 
Prevention, 2013). 
A study by Zhang and Rodriguez (2012) investigated racial/ethnic disparities in 
the prevalence of obesity and its related diseases in Massachusetts and assess disparities 
35 
 
in the risk of developing diseases related to overweight and obesity.  Hypertension and 
CVD are obesity-related diseases that were included in the outcome measures.  Blacks 
had higher odds of high blood pressure (OR = 1.88), heart attack (OR = 1.40) and stroke 
(OR = 2.14) than Whites. Hispanics were more likely to have high blood pressure (OR = 
1.34), high cholesterol (OR = 1.56), stroke (OR = 1.71), and heart attack (OR = 1.54) 
than Whites (Zhang & Rodriguez, 2012).   Health behaviors and disparities in blood 
pressure control were examined by race in a study using data from the NHANES in 
another study.  Data from NHANES were analyzed to conduct cross-sectional analyses 
among 21,489 U.S. adults aged >20 years participating in NHANES from 2001 to 2006 
(Redmond, et al., 2011).  Non-Hispanic Blacks were found to have 90% higher odds of 
poorly controlled blood pressure compared with non-Hispanic Whites after adjustment 
for sociodemographic and clinical characteristics (P<0.001) in primary analyses. In 
secondary analyses among hypertensive subjects, non-Hispanic Blacks and Mexican 
Americans had 40% higher odds of uncontrolled blood pressure compared with non-
Hispanic Whites after adjustment for sociodemographic and clinical characteristics 
(P<0.001). Additionally, for both analyses, the racial/ethnic differences in blood pressure 
control persisted even after further adjustment for modifiable health behaviors, which 
included medication adherence in secondary analyses (P<0.001 for both analyses) 
(Redmond, et al., 2011).  A cross-sectional study was conducted to determine whether 
being Black and having poor BP control interact to adversely affect patient-physician 
communication more than either condition alone.  This situation is referred to as "double 
jeopardy” by Cene, et al., (2009).  After controlling for patient and physician 
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characteristics, the researchers found that Blacks with uncontrolled BP have shorter visits 
with less biomedical, psychosocial, and rapport-building statements than Whites with 
controlled BP (Cene, et al., 2009).  A large amount of research has been done that 
demonstrates the impact of race on hypertension and CVD.  This research study goes 
further by linking race to other health disparity indicators to analyze their effect on CVD 
and hypertension. 
Impact of Age on CVD and Hypertension  
The literature was reviewed to investigate the impact of age as a risk factor for 
CVD and hypertension.  A study by Gupta (2014) analyzed multiple risk factors as well 
as self-reported CVD prevalence overall and discuss differences in prevalence by age.  
Analysis was conducted using Delaware data for 4,777 respondents from the 2011 
BRFSS.  Overall, 22.51% of persons reported having no risk factors, 32.30% reported 
one risk factor, and 45.20% reported multiple risk factors and prevalence of multiple risk 
factors was higher for the aged, less educated, and unemployed (Gupta, 2014).  
Age was found to be related to pre-hypertension in a study by Glasser, et al., 
(2011).  They conducted a cross-sectional analysis of 5,553 pre-hypertensives, 20,351 
people with hypertension, and 4,246 non-hypertensive participants (age >45 years) from 
the REasons for Geographic And Racial Differences in Stroke Study (REGARDS) data to 
determine racial, clinical, and demographic differences in the prevalence of pre-
hypertension and its cross-sectional association with vascular risk factors.  The 
prevalence of pre-hypertension increased by age and African-American race (Glasser et 
al., 2011).  
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The notion that in persons of older age, SBP is no longer associated with 
mortality was examined in the Rotterdam Study.  The Rotterdam Study is a population-
based prospective cohort study among 4,612 participants aged >55 years without 
previous cardiovascular disease and with a median follow-up of 14.9 (interquartile range, 
11.1-15.8) years (Blom, et al., 2013).  Analyses in the 5-year age groups revealed an 
increased risk with higher SBPs up to age 75 years, and after 75 years, a trend towards 
systolic blood pressure no longer being associated with an increased mortality risk was 
seen in the study (Blom, et al., 2013). 
Role of Gender in CVD and Hypertension Health Outcomes 
CVD are the main cause of death in women and men worldwide (Hochleitner, 
2013). According to Hochleitner (2013) Gender Medicine research has shown gender 
differences in cardiology to the detriment of women, for example it takes longer for them 
to receive and they are less likely to have access to high-tech medicine, such as the ICU, 
heart catheters, bypass surgery, and they have poorer outcomes (Hochleitner, 2013).  
Many research studies were found that examined gender in relation to hypertension and 
CVD health outcomes.  A specific focus was placed on the comparison of women by race 
and/or ethnicity in many of the articles that were reviewed.  For example, a review of the 
recent literature on the subject of CVD in women over the past several years was 
conducted with an emphasis on CVD in Black women and Caucasian women (Williams, 
2009).  According to Williams (2009), the mortality rate from coronary artery disease is 
69% higher in Black women than in Caucasian women.  Mortality for Black females was 
also found to be much higher (352%) from hypertension than for White females.   
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Hypertension and the specified cardiovascular events in this study that was conducted, 
compared male and female genders with each other, as well as with the other indicators.   
Gender was linked to other risk factors in the literature that was reviewed.  
Andersen and Jensen (2013) conducted a longitudinal study (i.e., the Copenhagen City 
Heart Study) of the association between income factors and trends in population blood 
pressure and hypertension. This Copenhagen City Heart Study is a prospective 
longitudinal epidemiological study on almost 20,000 individuals through four surveys 
from 1976 to 2003.  After adjusting for cardiovascular risk factors, there were no 
significant differences in systolic blood pressure trends associated with income among 
men. Among women, however, there was a reverse relationship between SBP and 
income. In addition, there was a trend towards a lowering of risk-factor adjusted SBP in 
the high income women with time (Andersen & Jensen, 2013). 
Community-based CVD programs that are tailored to reach women are needed.  
Altman et al., (2014) utilized a systems approach to develop, assess, and pilot a 
community-based education program for improving outcomes for knowledge/awareness 
of CVD, cardiometabolic risk, and health behaviors in Latinas.  It was determined that a 
bilingual culturally appropriate community-based CVD-prevention program based on 
health education, medical screenings, and empowerment is a successful, effective, 
adaptable, and replicable model to significantly improve cardiometabolic risk in Latinas 
(Altman et al., 2014). 
 CVD mortality was analyzed by gender in three different regions (27 countries) 
in a time series study of the Americas by Gawryszewski and Souza (2014).  During the 
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study period, the age-adjusted mortality rates for men were higher than those of females 
in all regions and North America showed lower rates than Latin America countries and 
the Non-Latin Caribbean (Gawryszewski & Souza, 2014).  A similar investigation in the 
U.S of gender along with other risk factors for CVD is much needed. 
Andersen and Jensen (2013) investigated the association between income factors 
and trends in population BP and hypertension in the prospective longitudinal Copenhagen 
City Heart Study among women.  They found that women in higher income groups have 
lower systolic blood pressure than women in low-income groups and the gap between 
SBP in high-income women and low-income women increased with time. There were no 
significant differences in SBP-trend associated to income among men (Andersen & 
Jensen, 2013).  
When gender is associated with race, Blacks continue to be the most 
disproportionately impacted.  Black women were compared to Caucasian women in 
regards to 4 categories of CVD: coronary artery disease (CAD), hypertension, stroke, and 
congestive heart failure (CHF) in a literature review (Williams, 2009).  The statistical 
findings from Williams’ (2009) review of the research over the past several years indicate 
that Black women have greater mortality than Caucasian women from CAD, 
hypertension, stroke, and CHF.  Incidence, prevalence, and morbidity figures for CAD, 
hypertension, stroke, and CHF are all higher for Black females than for Caucasian 
females (Williams, 2009). 
Role of Education in CVD and Hypertension Health Outcomes   
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There has been a long-standing inverse relationship between education and 
mortality that has strengthened substantially at the end of the 20th century (Cutler, et al., 
2011).  For example, during 1986 to 2002, the growing gradient for all-cause mortality 
reflected increasing mortality among low-educated women and declining mortality 
among college-educated women; during 2003 to 2006 it mainly reflected declining 
mortality among college-educated women (Montez & Zajacova, 2013).  
The need to understand the relationship of educational achievement with 
hypertension and CVD morbidity and mortality outcomes is important.  This is important 
because educational achievement has been negatively linked to numerous other health 
conditions and health outcomes (Cutler, 2011).  An example of a publication that used 
national data to study education was identified.  A cross sectional study using the 2006 
Behavioral Risk Factor Surveillance System (BRFSS) was conducted (Kelly & Weitzen, 
2010).  Among respondents aged 40 years and older to the 2006 BRFSS survey those 
with less than a high school education had 3.09 (95% CI: 2.79-3.43) times the odds of 
having had a myocardial infarction (MI) compared to college graduates. After adjusting 
for confounders, respondents with less than a high school education had 1.61 (95% CI: 
1.41-1.83) times the odds of having had an MI compared to college graduates.  
According to the researchers’ findings, participants with a high school education and 
those who completed some college or technical school were 1.22 times more likely to 




Education was often studied in conjunction with other indicators.  For example, 
Gupta (2014) examined the disparities associated with the risk factors for CVD in 
Delaware.  In the manuscript, the researcher stated that prevalence of multiple risk factors 
was higher for the aged, less educated, and unemployed.  This study, as well as many 
others that were reviewed, focused on state-level data.   
 Impact of Income on CVD and Hypertension Health Outcomes 
Income levels can be linked to the health outcomes of many diseases and 
conditions.  The relationships between income and hypertension, as well as CVD, were 
reviewed in the literature.  A good example is found in a study that was done to assess 
whether community affluence modifies the association between individual SES and six 
CVD risk factors: diabetes, hypertension, physical inactivity, obesity, smoking, and poor 
nutrition (Abeyta, et al., 2012). Data were stratified from the Colorado Behavioral Risk 
Factor Surveillance System for 2007 and 2008 based on individual socioeconomic status 
and three categories of community affluence (median household income of county). 
People who had a low SES seemed to benefit from residing in high-affluence 
communities. Living in high-affluence communities may counteract the effect of poverty 
on CVD risk factors.  Findings such as these support the value of interventions that 
address the social determinants of health (Abeyta, et al., 2012). 
Income studies have been done in other countries.  One such study examined 
hypertension screening campaigns in middle-income countries.   The researchers sought 
to identify socio-demographic predictors of hypertension prevalence, diagnosis, 
treatment, and control among 6 middle-income countries (China, Ghana, India, Mexico, 
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Russia, and South Africa) (Basu & Millet, 2013). Insurance status and income were 
found to be significant correlates to diagnosis and treatment probability (Basu & Millet, 
2013). 
The ability to obtain health insurance in the United Stares is more commonly 
linked to one’s ability to have a source of employment that provides health care coverage.  
Brooks, et al., (2010) investigated the relations of health insurance status to the 
prevalence, treatment, and control of major cardiovascular disease risk factors-
hypertension and elevated low-density lipoprotein (LDL) cholesterol-among Framingham 
Heart Study (FHS) participants in gender-specific, age-adjusted analyses among 6098 
participants.  At the time of the FHS clinic examination, 3.8% were uninsured and ages 
ranged from 19 to 64 years. The researchers concluded that treatment and control of 
hypertension and hypercholesterolemia were lower among uninsured adults (Brooks, et 
al., 2010).  Specifically, they found that: 1) the prevalence of hypertension and elevated 
LDL cholesterol was similar for the insured and uninsured; 2) the proportion of those 
who obtained treatment and achieved control of these risk factors was lower among the 
uninsured; and 3) uninsured men and women were less likely to be treated for 
hypertension (Brooks, et al., 2010).   
Hajat, et al., (2010) examined the relationship between wealth and three CVD risk 
factors (smoking, obesity and hypertension) in a U.S. population from the Panel Study of 
Income Dynamics (PSID) collected between 1999 and 2005.  They defined wealth as 
inflation-adjusted net worth and specified as a six category variable: one category for 
those with less than or equal to zero wealth and quintiles of positive wealth.  A weak 
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inverse association between wealth and hypertension incidence was found after 
controlling for income and other time-varying confounders (Hajat, et al., 2010). 
Research has been done on an aggregate basis across multiple countries on 
various income levels.  One study sought to identify sociodemographic predictors of 
hypertension prevalence, diagnosis, treatment, and control among middle-income 
countries.  The researchers analyzed data from 47,443 adults in 6 middle-income 
countries (China, Ghana, India, Mexico, Russia, and South Africa) sampled in nationally 
representative household assessments from 2007 to 2010 as part of the World Health 
Organization Study on Global Aging and Adult Health (Basu & Millett, 2013). 
Hypertension prevalence varied from 23% (India) to 52% (Russia), with between 30% 
(Russia) and 83% (Ghana) of people with hypertension undiagnosed before the survey 
and between 35% (Russia) and 87% (Ghana) untreated (Basu & Millett, 2013).  
Additionally, Basu and Millett (2013) found that insurance status and income emerged as 
significant correlates to hypertension diagnosis and treatment probability.  
Implications of Past Research on Present Research 
The literature was reviewed and the findings indicate that much research has been 
conducted on CVD and hypertension morbidity and mortality in general. Sentinel studies 
such as the Framingham Study (Lalonde, 2012; Turnbull, 2010) and the CDC article 
titled: Trends in Mortality Rates by Subtypes of Heart Disease in the United States, 2000-
2010 by Ritchey, et al., (2014) have established the foundation for this literature review.  
Subpopulations who are disproportionately impacted by morbidity and mortality 
indicators that are linked to CVD and hypertension were identified and analyzed in the 
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literature.  The findings from this literature and research will contribute to achieving 
health equity by addressing the health disparities in CVD and hypertension among those 
subpopulations who are disproportionately impacted.  According to the World Health 
Organization, health equity is “the absence of unfair, avoidable or preventable differences 
in health among populations or groups defined socially, economically, demographically 
or geographically” (World Health Organization, 2015, Paragraph 27).  
The CVD of focus include stroke, hypertensive disease, and chronic rheumatic 
heart disease.  The impact of CVD on hypertensive populations was established based on 
the past research.  There were specific subpopulations who were the most impacted when 
the indicators were also examined (Ritchey, et al., 2014; Satcher, 2008; Ford, 2011).  
These subpopulations included Blacks, low income groups and people with low 
educational attainment. Additionally, there were few research studies found that 
examined CVD and hypertension on the national level.  These studies examined some of 
the indicators also (Liao, et al., 2012; Ritchey et al., 2014).  However, there were no 
recent studies that examined the cumulative effect of three or more health disparities 
indicators of CVD in hypertension on a national level. 
Summary 
Each of the indicators (i.e., race, gender, education, income, age, and geographic 
location) was examined in relation to CVD and hypertension in this literature review.  
The availability of literature varied from a very large amount for race to a very small 
number of relevant articles for geographic location.  Morbidity and mortality health 
disparities were found to exist for CVD and hypertension for the indicators in certain 
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subpopulations.  In many instances, indicators were found to overlap in some 
subpopulations.  For example, race: Black, gender: female, and low income were linked 
to CVD (Williams, 2009; and O’Connor & Wellenius, 2012).  The cumulative effect of 
the indicators for CVD among hypertensive persons across the United States is of 
particular concern in this literature review.  Very few studies of this type were found.  
Although some preliminary research on states and communities explore the cumulative 
effect of the indicators for CVD among hypertensive persons, what has yet to be 
established in the literature are the impact of numerous indicators for CVD morbidity and 
mortality intersecting among people with hypertension in a national representative 
sample. 
The design for this study was chosen based upon a careful review of existing 
public health literature in the areas of surveillance research associated with CVD, 
hypertension, health disparities in CVD and hypertension, and the indicators for 
morbidity and mortality. Numerous state- and local-level research studies were found that 
examined the prevalence of cardiovascular diseases, as well as hypertension, and the 
associated risk factors on the state and local levels.  On the other hand, few studies were 
found that applied a health equity lens to national hypertension data and compared it with 
cardiovascular morbidity and mortality data across the geographic regions of the United 
States.  This study utilized national level data to analyze the cumulative effect of health 
disparity indicators on CVD morbidity and mortality among people with hypertension.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
The gaps in the literature that were described are addressed in the methods 
described in Chapter 3 of this study.  In Chapter 3, the cumulative effect of indicators 
46 
 
(i.e., race, gender, education, income, and geographic location) among individuals within 
certain subpopulations will be examined to determine whether or not there are significant 
differences in CVD morbidity and mortality outcomes among hypertensive 
subpopulations experiencing health disparities.   
 
Chapter 3: Research Method 
Purpose of the Study 
The purpose of this study was to examine the cumulative effect of demographic 
characteristics (i.e., race, gender, education, and income) on CVD health outcomes (i.e., 
coronary heart disease) among hypertensive subpopulations.  Surveillance data from 
across the United States between 1999 to 2010 was used to determine if there are 
significant differences in CVD morbidity and mortality outcomes among hypertensive 
subpopulations that are linked to CVD and hypertension health disparities.  I selected the 
years of 1999 to 2010 because they were the most recent data available that included the 
variables of interest.  Numerous studies have been conducted that link one or two (i.e., 
race and/or gender) indicators for health disparities to CVD morbidity and/or mortality 
(Loustalot, et al., 2014; Turnbull, 2010).  However, more research is needed to examine 
whether there are differences in health outcomes among subpopulations with 
hypertension who have numerous indicators for health disparities in comparison to 
subpopulations with hypertension who have one or fewer health disparities indicators.  In 
this study I explored this potential association between numerous demographic 
characteristics among persons with hypertension and/or CVD outcomes. 
47 
 
This chapter contains a description of the study’s design, sample, instrumentation, 
data analysis, and ethical considerations.  An overview of the study’s design includes a 
rationale for why I selected this specific research design.  I presented the sample 
characteristics and size as well as a description of the instrumentation.  I also discussed 
the data collection process and analysis. 
Research Design and Rationale 
I utilized the quantitative cross-sectional observational study design for this study.  
Study Variables 
 Dependent variable.  The dependent variables were blood pressure readings, 
being told that you had high blood pressure as well as CVD morbidity and mortality 
variables from the National Health and Nutrition Examination Survey (NHANES).  I 
extracted other variables related to CVD morbidity and CVD mortality data variables 
(i.e., coronary heart disease, acute myocardial infarction, and cardiac dysrhythmia from 
International Classification of Diseases, 9th and 10th Revision (ICD-9 and 10 Codes) 
codes of the National Death Index (NDI) survey.   
 Independent variable.  Independent variables were hypertension, education 
level, household income, race/ethnicity, body mass index (BMI), and gender.  I obtained 
each of the independent variables from NHANES.  Hypertension is defined as 140 
mmHg or higher systolic, and/or 90 mmHg or higher diastolic (U.S. Preventive Services 





Research Design   
In this cross-sectional observational study, I analyzed multiple demographic 
characteristics (i.e., indicators for health disparities) and generalized from large samples 
to the United States population.  The cross-sectional observational study was appropriate 
because it provides a numeric description of the relevant trends of certain subpopulations 
in the United States (Creswell, 2009).  The cross-sectional observation study is less 
expensive and time consuming than a longitudinal study.  Specifically, I utilized 
secondary data analysis on previously collected data to explore potential differences in 
health outcomes among subpopulations with hypertension who have varying indicators 
for health disparities, as well as address the research questions by studying a sample of 
that population.  The population and sample data from the cross-sectional study is 
collected at one specific point in time versus a period of time.  This has assisted me in 
completing the study within a reasonable period of time.  I utilized this research design to 
address the research questions and the purpose by allowing multivariate analyses, 
absolute, and relative risks to be calculated from the prevalence of CVD morbidity and 
mortality between hypertensive subpopulations. 
Methodology 
Study Population 
The population of this study consists of the participants who were screened, 
interviewed, and examined between 1999 to 2010 in alignment with the data that are 
available from the National Death Index.  The information gathered by NHANES 
provides a glimpse of the health and nutrition for a broad range of age groups as well as 
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racial/ethnic characteristics of the United States population (Centers for Disease Control 
and Prevention, 2015).  The study participants are found in 15 randomly selected counties 
across the United States.   
Study Sample 
Inclusion criteria. For this research study, the sample consists of persons 
identified in NHANES data between the years of 1999-2010.  I calculated the rates of 
hypertension for various subgroups.  In addition, I conducted analyses on the persons 
with hypertension who are 30 years and older.  I selected this age range because it 
represents the majority of the adult population who are most vulnerable to hypertension 
and CVD (Centers for Disease Control & Prevention, 2015).  The sample with 
hypertension was defined by persons who answered yes to at least one of the following:  
ever told that they had high blood pressure (blood pressure readings which are at least 
140 millimeters of Mercury (mmHg) systolic and/or at least 90 mmHg diastolic);  told 
had high blood pressure two or more times; or taking prescriptions for hypertension.   
Exclusion criteria. I excluded persons who are under the age of 30 years old 
from the study. Additionally, I excluded persons with blood pressure readings of less than 
140 mmHg systolic and less than 90 mmHg diastolic that were taken during the physical 








This is a cross-sectional study in which I utilized secondary data from a large 
publicly available and nationally representative data set.  For this study, I computed a 
priori power analysis to establish the required sample size, given Alpha (α), power, and 
effect size. I assumed a small effect size of 0.25, along with a power of 0.80 (1-β error 
probability) and alpha of error probability of 0.05. The resulting sample size was 95 total 
participants for both research questions using multiple regression statistical tests of four 
variables.  The large sample size (at least 1,000 participants) in this study exceeds the 
power needed.   A statistical program such as G*Power can be used to determine the 
appropriate study sample size.  G*Power is designed to be a stand-alone power analysis 
program for statistical testing (Kraemer & Thiemann, 1987).   
Procedures for Recruitment, Participation, and Data Collection 
The NHANES survey conducted by the CDC is the original study and it served as 
the data source for this study (CDC, 2015).  Population data were collected on the 
prevalence of chronic conditions such as hypertension and diabetes.  Personal interviews, 
physical examinations, laboratory tests, nutritional assessments, and a DNA repository 
are the primary data sources and methods of NHANES.  The home interview and the 
physical examination were the two main sources of data for this study.        
NHANES home interview. The NHANES home interview consisted of 
demographic, socioeconomic, dietary, and health-related questions.  The interviewer only 
interviewed those individuals who were at least 18 years-old.  During the home 
interview, participants were asked questions about their health, disease history, and diet.  
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There were questions that were relevant to my research study.  The questionnaire was 
retrospective, and I placed a particular interest on the questions that focus on 
hypertension and CVD.  I extracted the participants’ responses to these questions.  
Physical examination. The physical examination consisted of a number of 
measurements and tests that are contingent upon the age, gender and self-reported 
medical conditions of the participants.  Medical, dental, and physiological measurements, 
and laboratory tests make up the physical examination portion of NHANES (CDC, 2015). 
I analyzed the participants’ blood pressure readings from the physical examination.  
Procedures for Recruitment. The following procedures for recruitment were 
used in the original NHANES study.  The communities and participants within those 
communities were selected using a complex, multistage probability sampling design 
(CDC, 2013).  The researchers divided the United States into communities that were 
subdivided into randomly selected neighborhoods.  From each neighborhood, housing 
units were selected at random. Selected households were approached by the NHANES 
interviewers who asked residents a few short questions to determine if individuals in the 
household were eligible.  A computer algorithm randomly selects all, some, or none of 
the members of the household.  According to the CDC (2015), approximately 5,000 
persons are selected each year in 15 counties representing around 50,000 other U.S. 
residents. Persons 60 years-old and up, Blacks, and Hispanics are oversampled to 
increase the reliability and precision of estimates of health status indicators for these 
population subgroups (CDC, 2015).  The identities of the participants are held strictly 
confidential.  NHANES is a publicly accessible database and access and necessary 
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permission to restricted data items in the data set are gained by submitting a proposal to 
the Research Data Centers at the NCHS.  The information needed for this research study 
can be obtained from the publicly available data sets.  
  
Instrumentation 
   The United States Department of Health and Human Services created the National 
Center for Health Statistics (NCHS) in 1959.  The NCHS is an agency at the who 
manages NHANES and the Behavioral Risk Factor Surveillance System (BRFSS).  In 
addition, NCHS extracts mortality data files from the National Death Index (NDI) survey 
and links that data to NHANES.  NHANES has undergone revisions and updates 
throughout the years. The current version of NHANES began in 1999 (CDC, 2013).  
Health interviews were used to collect the data at the participants’ homes and from 
mobile examination centers.  These are highly equipped medical vans that are driven by 
the NHANES examiners.  The health interviews consisted of home interviews and the 
physical examinations of the selected participants followed by laboratory testing.  
According to the CDC (2013), the oversampling of the participants that was previously 
mentioned helps to increase the reliability and precision of the health status indicators for 
the selected population subgroups.   
The information, such as the blood pressure and cardiovascular disease questions, 
which is collected from the health interviews are closely related to the variables of 
interest in the current study.  The demographic, hypertension, and CVD variables from 
the current study can be identified in the home interviews and physical examinations.  
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Demographic variables that were collected from NHANES participants during the home 
interviews include: race, gender, age, education and income.  The demographic 
characteristics were used as composite variables and compared based on the relevant 
CVD and hypertension variables from NHANES.  Variable scores for the demographic 
characteristics were developed based on the level of risk for CVD mortality and 
morbidity.  For example, the variable scores for race were determined for Blacks, Whites, 
Asians, Hispanics and others.  The subpopulation with the highest risk for CVD mortality 
received a score of 5 followed in descending order by the other racial groups.  Frequency 
distributions of scores from high to low risks were developed.  The following CVD and 
hypertension variables with their descriptions were retrieved from NHANES.  They were 
helpful in answering the research questions.  
Operationalization of the Variables 
The operational definitions of education level, household income, race/ethnicity, 
and gender can be found in the variable tables below.  Control variables are taking 
hypertension medications, taking cardiovascular medications, smoking, and 
cardiovascular fitness.      
NHANES Variables  
The following tables contain descriptions of the demographic, dependent, and 
outcome variables for education level, gender, age, race/ethnicity, household income, 








Highest Education Level Achieved by Adults  
Code or Value Value Description (Ordinal level of measurement) 
1 Less Than 9th Grade 
2 9-11th Grade (Includes 12th grade with no diploma) 
3 High School Grad/GED or Equivalent 
4 Some College or AA degree 
5 College Graduate or above 
7 Refused 




Table 2  
 
Gender of Participants 







Age of Participants at Screening 
Code or Value Value Description (Ordinal level of meas.) 
0 to 84 Range of Values 










Table 4   
 
Race/Ethnicity of Participants  
Code or Value Value Description (Nominal level of meas.) 
1 Non-Hispanic White 
2 Non-Hispanic Black 
3 Mexican American 
4 Other Race - Including Multi-Racial 
5 Other Hispanic 
 
Table 5   
 
Annual Household Income of Participants 
Code or Value Value Description (Nominal level of meas.) 
1 $ 0 to $ 4,999 
2 $ 5,000 to $ 9,999 
3 $10,000 to $14,999 
4 $15,000 to $19,999 
5 $20,000 to $24,999 
6 $25,000 to $34,999 
7 $35,000 to $44,999 
8 $45,000 to $54,999 
9 $55,000 to $64,999 
10 $65,000 to $74,999 
11 $75,000 and Over 
12 Over $20,000 
13 Under $20,000 
 
Table 6   
 
Body Mass Index (BMI) of Participants  
Both males and females 2yrs. – 150 yrs. 
Code or Value Value Description 





Dependent and Outcome Variables: 





SAS Label Variable Description 
BPQ020 
Ever told you had high 
blood pressure 
{Have you/Has} ever 
been told by a doctor 




called high blood 
pressure? 
BPQ030 
Told had high blood 
pressure - 2+ times 
{Were you/Was} told 
on 2 or more different 
visits that {you/s/he} 
had hypertension, also 
called high blood 
pressure? 
BPQ040A 
Taking prescription for 
hypertension 
Because of (high blood 
pressure/hypertension), 
{have you/has s/he} 




Systolic: Blood pressure 
(first reading) mm Hg 
BPX_H 
BPXDI1 
Diastolic: Blood pressure 
(first reading) mm Hg 
BPX_H 
BPXSY2 
Systolic: Blood pressure 
(second reading) mm Hg 
BPX_H 
BPXDI2 
Diastolic: Blood pressure 





Systolic: Blood pressure 
(third reading) mm Hg 
BPX_H 
BPXDI3 
Diastolic: Blood pressure 
(third reading) mm Hg 
 
BPXSY4 
Systolic: Blood pressure 
(fourth reading) mm Hg 
BPX_H 
BPXDI4 
Diastolic: Blood pressure 
(fourth reading) mm Hg 
 
 
CVD Morbidity Variables  
Table 8   
 
Ever had pain or discomfort in chest  
Both males and females 40 YEARS - 150 YEARS 


















Table 9  
  
Severe pain in chest more than half hour 
Both males and females 40 YEARS - 150 YEARS 




9 Don't know 
. Missing 
 
ICD Codes from the NDI 
Tables 8 and 9, as well the ICD 9 Morbidity (Hospitalization) codes below, 
contain the symptoms and conditions that indicate CVD morbidity in the sample.  ICD 10 
Mortality Codes below that are found in the NDI survey form the morbidity variable.  
These codes are extracted by the NCHS from the NDI survey and linked to NHANES 
data.  The following list contain the ICD 9 and 10 codes that indicate CVD mortality 
and/or morbidity outcomes in this research study. 
Morbidity (Hospitalizations) from the NDI Survey: ICD-9 Codes 
 
• All Heart Disease: 390-398, 402, 404, 410-429; principle (i.e., first-listed)  
diagnosis. 
• Coronary Heart Disease: 410-414, 429.2; principle (i.e., first-listed) diagnosis. 
• Acute Myocardial Infarction: 410; principle (i.e., first-listed) diagnosis. 
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• Cardiac Dysrhythmia: 427; principle (i.e., first-listed) diagnosis. 
• Heart Failure: 428; principle (i.e., first-listed) diagnosis. 
• Hypertension: 401-405; principle (i.e., first-listed) diagnosis. 
 
Mortality from the NDI Survey: ICD-10 Codes 
 
• All Heart Disease: I00-I09, I11, I13, I20-I51; underlying cause of death. 
• Coronary Heart Disease: I20-I25; underlying cause of death. 
• Acute Myocardial Infarction: I21-I22; underlying cause of death. 
• Cardiac Dysrhythmia: I47-I49; underlying cause of death. 
• Heart Failure: I50; deaths with heart failure mentioned in any of the 20 listed  
causes of death on the death certificate. 
• Hypertension: I10-I15; deaths with hypertension mentioned in any of the 20 listed 
 causes of death on the death certificate. 
 
Data Analysis 
SAS software was used to analyze the data.  Descriptive statistics was used first to 
describe the basic features of the data and provide summaries about the sample and the 
measures.  The best and worst groups will be identified according to the CVD morbidity 
and mortality outcomes.  Descriptive statistics were used to point out variables that 
should be further examined.  The CVD morbidity variables for chest pain and 
hospitalization codes from ICD-9, as well as the ICD-10 Mortality Codes, were counted 
to determine the number of CVD related morbidity and mortality diagnoses.     






 Multivariate Analyses   
Multivariate analyses were performed to assess associations between CVD 
outcomes and multiple risk factors for CVD morbidity and mortality amongst those with 
hypertension who may have numerous health disparities risk factors.  The absolute, 
relative and percent variations of the demographic variables for mortality and morbidity 
were computed.  Regression models were used to assist in investigating the relationships 
between the dependent variables and the independent variables.  Logistic regression was 
used to analyze the CVD morbidity and mortality variables from the ICD-9 and ICD-10 
codes to identify the relevant diagnoses.  In addition, interaction variables were identified 
and used with regression modelling to better understand the relationships among the 
variables.  
Absolute Difference and Relative Difference.  The absolute difference is 
calculated by subtracting the rate for a reference population from the rate from the other 
populations.  The relative difference is obtained by dividing the absolute difference by 
the rate for the reference population and the result is expressed as a percentage of the rate 
for the reference population.  In this study, the absolute and relative differences in CVD 
outcomes for racial/ethnic groups were calculated by identifying the Race/Ethnic group 
with the best CVD outcomes and considering them to be the reference group.  This 
reference group is compared to the other Race/Ethnic groups. 
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 Table10 aligns the research questions with the relevant study variables and 
statistical analyses that were utilized in this research study.  
 
Table 10  
 
Statistical Analyses  
 
Research Questions Variable(s) Analyses 
RQ1: Are there significant 
differences in the selected 
CVD morbidity outcomes 
between hypertensive 
subpopulations, ages 30 
years and up, experiencing 
health disparities and the 
best group (i.e., the 
subpopulation with the best 
CVD morbidity outcomes) 
in the United States for 
hypertension and when 
three or more indicators 
(i.e., race, gender, 
education, income) 
intersect?   
The following variables 
include: CVD morbidity as 
a dependent variable; age, 
education level, household 
income, race/ethnicity, 
body mass index (BMI), 
and gender are the 
independent variables.  
Other covariates are 
hypertension medications, 
taking cardiovascular 



















CVD Covariates  








Multivariate Analysis  
Regression Models, Logistic Regression and 
Interaction Variable 
Absolute and Relative Differences 
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RQ2: What are the 
significant differences in 




disparities and the best 
group (i.e., the 
subpopulation with the best 
CVD mortality outcomes) 
with hypertension in the 
United States when three or 
more indicators (i.e., race, 
gender, education, income) 
intersect?  The following 
variables that are relevant 
to this question include: 
CVD mortality as a 
dependent variable; 
education level, household 
income, race/ethnicity, 
BMI, and gender are the 
independent variables.  
Other covariates are: 
hypertension medications, 
taking cardiovascular 
medications, smoking, and 



























Multivariate Analysis  
 Regression Models, Logistic Regression and 
Interaction Variable 
Absolute and Relative Differences 
 
Research Questions and Hypotheses 
The following research questions and hypotheses were used to test the cumulative 
effect of demographic variables on CVD morbidity and mortality among persons with 
hypertension in the United States.   
RQ1: Are there significant differences in the selected CVD morbidity outcomes 
between hypertensive subpopulations, ages 30 years and older, experiencing health 
disparities and the best group (i.e., the subpopulation with the best CVD morbidity 
63 
 
outcomes) in the United States for hypertension and when three or more of the following 
indicators intersect?   
Indicators among individuals within certain subpopulations include race, gender, 
age, education, and income.   
Selected CVD morbidity include reporting severe pain in the chest more than 
half hour and pain or discomfort in chest reported by participants in NHANES.  Coronary 
heart disease, acute myocardial infarction, cardiac dysrhythmia, and heart failure reported 
in NDI survey. 
H10:  There are no significant differences in cardiovascular disease morbidity 
outcomes between hypertensive subpopulations experiencing health disparities and the 
best group in the United States for hypertension and when three or more indicators 
intersect. 
H1A: There are significant differences in cardiovascular disease morbidity 
outcomes between hypertensive subpopulations experiencing health disparities and the 
best group in the United States for hypertension and when three or more indicators 
intersect. 
RQ2: What are the significant differences in cardiovascular disease mortality 
outcomes between hypertensive subpopulations experiencing health disparities and the 
best group (i.e., the subpopulation with the best CVD mortality outcomes) in the United 
States for hypertension and when three or more of the following indicators intersect?     
Indicators among individuals within certain subpopulations include race, gender, 
age, education, and income.   
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Selected CVD mortality include coronary heart disease, acute myocardial 
infarction, cardiac dysrhythmia, and heart failure reported in the NDI survey. 
H20:  There are no significant differences in cardiovascular disease mortality 
outcomes between hypertensive subpopulations experiencing health disparities and the 
best group in the United States for hypertension and when three or more indicators 
intersect. 
H2A: There are significant differences in cardiovascular disease mortality 
outcomes between hypertensive subpopulations experiencing health disparities and the 
best group in the United States for hypertension and when three or more indicators 
intersect. 
  Descriptive statistics, bivariate analyses, and multivariate analyses with 
Regression Models were used to test the cumulative effect of demographic variables on 
CVD morbidity and mortality among persons with hypertension in the United States for 
the research questions and hypotheses.  Specifically, descriptive statistics described the 
basic features of the data and provided summaries.  A bivariate analysis was conducted to 
analyze hypertension and CVD to determine the empirical relationship between them, as 
well as test simple hypotheses of association.  Multivariate analyses were performed to 
assess changes in the risk for CVD morbidity and mortality among those with 
hypertension who may have numerous health disparities risk factors.  The absolute, 
relative and percent differences of the demographic variables for mortality and morbidity 
were computed.  The specific variables that were presented are the following dependent 
variables: 1) CVD morbidity – hospitalizations for pain or discomfort in the chest and 
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coronary heart disease, acute myocardial infarction, heart failure and cardiac dysrhythmia 
diagnoses.  2) CVD mortality – death as a result of coronary heart disease, acute 
myocardial infarction, heart failure and cardiac dysrhythmia diagnoses.  Independent 
variables are education level, age, household income, race/ethnicity, body mass index 
(BMI), and gender.  Having hypertension is an inclusion criterion for this study.  Other 
covariates are: hypertension medications, taking cardiovascular medications, smoking, 
and cardiovascular fitness, cholesterol levels, and hemoglobin A1-C levels.  This study 
will use CVD event surveillance data and secondary data analysis to respond to the 
research questions.   
Descriptive statistics were performed on the following demographic variables: 
age, gender, race/ethnicity, education and income.  Bivariate analysis using the 
hypertension indicators on CVD morbidity and mortality from the NDI.  Regression 
analyses will be done using the demographics by morbidity and mortality from NDI, 
hypertension indications and CVD conditions.  Interaction variables will be identified and 
used with regression modelling to better understand the relationships among the 
variables. 
Threats to Validity 
This study focuses on relationships between hypertension, cardiovascular disease 
and indicators of health disparities.  Given that this study is both cross-sectional and 
correlational, causation was not assessed.  Internal validity is much stronger for 
experimental designs than for correlational designs.  The interview portion of NHANES 
is retrospective.  Difficulty remembering is a major limitation of retrospective studies.  
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For example, recalling if they were told that they had high blood pressure two or more 
times may be difficult for some of the participants.  This may result in inaccurate or 
biased recall.  Additionally, it cannot be assumed that correlation leads to causation.  
Since the intent of this study is to determine if a relationship exist between the indicators 
for health disparities and hypertension and CVD, a correlational design was appropriate 
in spite of its limitations.  
Ethical Procedures 
NHANES serves as the primary data source for this research project.  The ethical 
concerns regarding access to participants and the treatment of data were addressed by the 
researchers who plan and execute NHANES.  Agreements to access data are not needed 
because it is available for public use.  Data were stored and maintained in an electronic 
file on a computer that is password protected and will be kept for at least five years.  
Human participation is not a factor because this is secondary data.  However, all 
guidelines were followed and relevant approval from Walden IRB regarding the 
treatment of human subjects and data was obtained.  Data was anonymous and 
confidential.  The primary researcher has access to the data along with the two committee 
members. 
Summary 
This research study examined whether there are differences in health outcomes 
among subpopulations with hypertension who have numerous demographic 
characteristics that are health disparities indicators for CVD in comparison to 
subpopulations with hypertension who have one or fewer health disparities indicators.  
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This cross-sectional observational study analyzed multiple demographic characteristics 
among people with hypertension that are indicators for health disparities and generalized 
from large samples to the U.S. population using surveillance data from NHANES.  The 
demographic characteristics were analyzed and compared based on the relevant CVD and 
hypertension variables from NHANES.  The cumulative effect of variables was 
determined by quantifying the variables that merge across CVD and morbidity and 
mortality among people with hypertension in the study population to assess disparities 
and changes in disparities.  
The next chapter discusses the data analysis and results.  In Chapter 4, the 
cumulative effect of indicators (i.e., race, gender, education, and income) will be 
analyzed to determine if there are significant differences in CVD morbidity and mortality 
outcomes among hypertensive subpopulations experiencing health disparities.  
Additionally, the multivariate analysis, the relative risks of the combined variables, and 
the index of disparity results for each of the groupings will be analyzed.  
 
Chapter 4: Results 
Introduction 
The purpose of this research was to explore the cumulative effect of demographic 
characteristics such as race, gender, age, education, and income to determine if there are 
significant differences in CVD morbidity and mortality outcomes among hypertensive 
subpopulations that are linked to CVD and hypertension health disparities.  The research 
questions and hypotheses were:  
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RQ1: Are there significant differences in the selected CVD morbidity outcomes 
between hypertensive subpopulations, ages 30 years and older, experiencing health 
disparities and the best group (i.e., the subpopulation with the best CVD morbidity 
outcomes) in the United States for hypertension and when three or more of the following 
indicators intersect?   
H10:  There are no significant differences in cardiovascular disease morbidity 
outcomes between hypertensive subpopulations experiencing health disparities and the 
best group in the United States for hypertension and when three or more indicators 
intersect. 
H1A: There are significant differences in cardiovascular disease morbidity 
outcomes between hypertensive subpopulations experiencing health disparities and the 
best group in the United States for hypertension and when three or more indicators 
intersect. 
RQ2: What are the significant differences in cardiovascular disease mortality 
outcomes between hypertensive subpopulations experiencing health disparities and the 
best group (i.e., the subpopulation with the best CVD mortality outcomes) in the United 
States for hypertension and when three or more of the following indicators intersect?   
 H20:  There are no significant differences in cardiovascular disease mortality 
outcomes between hypertensive subpopulations experiencing health disparities and the 




H2A: There are significant differences in cardiovascular disease mortality 
outcomes between hypertensive subpopulations experiencing health disparities and the 
best group in the United States for hypertension and when three or more indicators 
intersect. 
This chapter is organized into the following sections: data analysis, results, and 
summary. 
Data Collection 
The data were collected by the NHANES from 1999-2010 from the U.S. 
population residing in 15 counties per year in the United States (CDC, 2017).  The 45,033 
respondents from all age and gender groups were recruited from various counties across 
the United States.  9,296 respondents with hypertension who were 30 years and older met 
the criteria and were found to be eligible for the research study.  It was also necessary to 
identify study participants who were taking prescribed hypertension medication.  There 
were 8,781 participants with hypertension who stated that they were prescribed 
medication to control their blood pressure.  Additionally, 7,236 participants were 
identified who stated that they are now taking prescribed hypertension medication).  
Amongst people with hypertension, the hypertension medication use of the 
subpopulations with at least two or more health disparity indicators were compared to 
those with one or less health disparity indicator in Table 11 (CVD Morbidity) in order to 
assess whether there was a confounding effect.  It was found that no significant 
difference in medication use existed between those persons with 0 to 1 health disparity 
indicators (i.e., age, education, race, gender and income) who were taking hypertension 
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medications and those with 2 or more health disparity indicators who were taking 
medication for hypertension for CVD morbidity.   
Table 11  
Odds Ratios with Point Estimates for Persons Taking Hypertension Medication Among 
Health Disparity Indicator Categories for Adults 30 Years and Older With Hypertension 
for CVD morbidity 
Hypertension Medication Use among 
Health Disparity Indicator Categories 
Point Estimates 
Odds Ratios 
  (95% CL) 
BP Medication Cat 2 vs 1  
1.083 (0.896-1.307) 
BP Medication Cat 3 vs 1      
1.003 (0.811-1.240) 
BP Medication Cat 4 vs 1 1.065 (0.761-1.491) 
 
Table 12 contains the descriptions, types and coding for the independent and dependent 
variables of this study.  I found no discrepancies in the data collection for the plan that 
was presented in Chapter 3.  The sample included participants from all race/ethnicities 
who were hypertensive, 30 years and older of both genders.  A complex, multistage 
probability design with a larger sample size is used by NHANES in order to increase the 
reliability and accuracy of the health status of the target population, and to ensure the 









Independent and Dependent Variable Coding 





Highest Education Level 
Achieved 
Categorical 1= Less Than High School 
  2= High School Diploma 
  3=Some college or AA degree 
  4=College graduate or above 
Race/Ethnicity Nominal 1=Caucasian or White 
  2=Black 
  3=Hispanic 
  
4= Other Race (Including Multi-
racial) 
Poverty Income Ratio (PIR) Categorical 1=Income below poverty level 
  0= Income above poverty level 
Gender Categorical 1=Male 
  2=Female 
Age Interval 30 Years and older 
 Categorical 1=30-44 years 
  2=45-54 years 
  3=55-64 years 
  4=66-74 years 
  5=75-79 years 
  6=80+ years 
Told to take BP Medication Categorical 1=Yes 
  2=No 
Now Taking BP Medication Categorical 1=Yes 
  2=No 





Morbidity Categorical 1=Yes 
  2=No 
Mortality Categorical 1=Yes 
  2=No 
Hypertension Categorical 1=Yes 







Data for this study were analyzed using SAS v. 9.4. The types and data coding for 
the independent and dependent variables are listed in Table 12.  The unweighted totals, 
row percent, standard errors, and categories for the variables in this study are presented in 
Table 13.  The crude associations with unweighted frequencies and row percent for CVD 
morbidity among hypertensive adults 30 years and older are presented in Table 14.  
Participants who were between the ages of 66-74 years-old (n=505), male gender 
(n=958), participants whose income is above the poverty level (n=1,259), Caucasians or 
Whites (n=1,018), and persons with less than a high school diploma (n=709) had the 
highest frequency in each of their categories. The crude associations with unweighted 
frequencies and row percent for CVD mortality among hypertensive adults 30 years and 
older are found in Table 15. Participants who were 80+ years-old (n=218), male gender 
(n=350), participants whose income is above the poverty level (n=406), Caucasians or 
Whites (n=345), and persons with less than a high school diploma (n=283) had the 
highest frequency of CVD mortality in each of their categories.  However, the findings 
differed in many of the indicators when the dataset was analyzed to identify those 






Table 13.  









Total   9296   
Age         
 30-44 years 962 14.42 0.677 
 45-54 years 1474 23.22 0.737 
 55-64 years 2103 22.44 0.553 
 66-74 years 2346 21.09 0.525 
 75-79 years 939 8.25 0.354 
 80+ years 1472 10.57 0.405 
Gender       
 Male 4514 46.84 0.569 
 Female 4782 53.16 0.569 
PIR        
 
Income below 
poverty level 1513 11.93 0.512 
          
Income above 
poverty level 6981 88.06 0.512 
Race/Ethnicity     
 
Caucasian or 
White 4744 73.73 1.49 
 Black 2266 13.75 1.084 
 Hispanic 2002 8.37 1.282 
 
Other (Including 
Multi-racial)  765 4.14 0.349 
Education 
Level     
 
Less Than High 
School 3402 24.76 0.735 
 
High School 
Diploma 2299 28.09 0.713 
 Some college 2172 27.15 0.783 
 College graduate  1398 19.99 0.793 
CVD      
 Morbidity 1729 18.11 0.654 





Table 14.  
 
Crude Associations for CVD Morbidity Among Adults 30 Years and Older With 
Hypertension, n=1,729. 
Health Disparity 
Indicators  Frequency Percent 
       
 30-44 years 47 0.702 
Age 45-54 years 151 2.22 
 55-64 years 339 3.73 
 66-74 years 505 5.27 
 75-79 years 257 2.59 
 80+ years 430 3.59 
    
Gender Male 958 9.28 
 Female 771 8.82 
 Income below poverty level 312 2.83 
Poverty Income Ratio 
(PIR)    Income above poverty level 1259 15.17 
             
 White 1018 14.08 
Race/Ethnicity Black 388 2.35 
 Mexican American 219 0.539 
 
Other Race (Including Multi-
racial) 104 1.14 
    
Education Level Less Than High School 709 5.98 
 High School Diploma 431 5.16 
 Some college or AA degree 403 4.74 
 College graduate or above 180 2.21 



















Indicators  Frequency Percent 
Age        
 30-44 years 17 0.227 
 45-54 years 38 0.531 
 55-64 years 79 0.690 
 66-74 years 162 1.322 
 75-79 years 85 0.701 
 80+ years 218 1.539 
Gender      
 Male 350 2.231 
 Female 249 2.779 
PIR       
 Income below poverty level 130  0.925 
          Income above poverty level 406 3.987 
Race/Ethnicity    










 Hispanic 85 0.033 
 






Education Level    











Some college or AA degree 












Research Question 1  
I derived the following statistical findings from two primary research questions 
and associated hypotheses that were aligned with the relevant study variables and 
statistical analyses.   
  RQ1: Are there significant differences in the selected CVD morbidity outcomes 
between hypertensive subpopulations, ages 30 years and older, experiencing health 
disparities and the best group (i.e., the subpopulation with the best CVD morbidity 
outcomes) in the United States for hypertension and when three or more of the following 
indicators intersect? (Health disparity indicators-age, gender, PIR, race/ethnicity, and 
education level).  
H01: There are no significant differences in the selected CVD morbidity outcomes 
between hypertensive subpopulations experiencing health disparities and the best group 
with hypertension in the United States when three or more indicators intersect was the 
null hypothesis that was rejected.  Of the 9,296 participants with hypertension, there were 
686 cases of CVD reported.  I conducted multivariable analyses within and across the 
five disparity indicators (i.e., age, sex, race/ethnicity, poverty-income ratio, and education 
level) to examine CVD morbidity among participants with hypertension who are 30 years 
and older.  As indicated in Table 16, CVD morbidity increased as: participants got older 
(i.e., participants who were 80+ years-old were ten times more likely than those who 
were between the ages of 30-44 years); in males versus females; participants with 
incomes below the poverty level were 1.5 times more likely to report CVD morbidity 
than those whose income was above the poverty level; and in those participants who are 
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Black.  Participants were also less likely to experience CVD morbidity as their education 
level increased.  Those with less than high school education were 2.5 times more likely to 
report CVD morbidity in comparison to participants who were college graduates are 
above.      
Table 16.  
 
Odds Ratios with Point Estimates for CVD Morbidity Among Adults 30 Years and Older 
With Hypertension, n=9,296. 
 Point Estimates 
Odds Ratios 
  (95% CL) 
Age   
30-44 years Comparison grp.  
45-54 years 1.974 (1.311-2.972) 
55-64 years 3.752 (2.476-5.686) 
66-74 years 6.505 (4.515-9.370) 
75-79 years 8.791 (6.202-12.460) 
80+ years 10.153 (6.878-14.989) 
Sex   
Male Comparison grp.  
Female 0.766 (0.673-0.873) 
Poverty-income ratio   
Income below poverty level 1.544 (1.308-1.822) 
Income above poverty level Comparison grp.  
Race/ethnicity   
Caucasian or White Comparison grp.  
Black 0.890 (0.755-1.050) 
Hispanic 0.641 (0.520-0.790) 
Other Race (Including Multi-racial) 
0.716 (0.488-1.049) 
Education level   
Less Than High School 2.514 (2.035-3.107) 
High School Diploma 1.837 (1.420-2.375) 
Some college or AA degree 1.741 (1.397-2.169) 
College graduate or above Comparison grp.  
 
I determined health disparities among people with hypertension in this research 
study by identifying those subpopulations within the health disparity indicators (i.e., age, 
gender, PIR, race/ethnicity, and education level) who were bearing the highest burden of 
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CVD morbidity.  I assessed interactions between the health disparity indicators and 
morbidity outcomes by assigning Health Disparity Indicator Scores to the health disparity 
indicators. The subcategories in the health disparity indicators were assigned a score of 0 
for the comparison group (i.e., college graduate or above for education level) or 1 for the 
group with the highest disparity (i.e., less than high school for education level). 
According to Table 17, there were significant differences in CVD morbidity outcomes 
between hypertensive subpopulations experiencing health disparities when three or more 




Odds Ratios with Point Estimates for Health Disparity Indicator Scores for CVD 
Morbidity Among Adults 30 Years and Older With Hypertension 




  (95% CI) 





2 vs. 0 
12.797 (2.725-60.093) 
3 vs. 0 
15.710 (3.232-76.356)       
4 vs. 0 
12.516 (2.544-61.580)       
 
However, Health Disparity Indicator Score Categories for the health disparity 
indicators (i.e., age, gender, PIR, race/ethnicity, and education level) were created to 
combine scores with small frequencies and large confidence intervals.  Category 1 
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contains 0 to 1 health disparity indicators, Category 2 contains two health disparity 
indicators, category 3 contains 3 health disparity indicators, and category 4 contains 4 to 
5 health disparity indicators.  Table 18 shows that the CVD morbidity increases 
significantly as the number of health disparity indicators increase. There were significant 
differences in CVD morbidity outcomes between hypertensive subpopulations who were 
30 years and older experiencing health disparities when up to three health disparity 
indicators intersect in comparison to participants with 0 to 1 health disparity indicator.   
Table 18.  
Odds Ratios with Point Estimates for Health Disparity Indicator Score Categories for 
CVD Morbidity Among Adults 30 Years and Older With Hypertension 




  (95% CL) 
HDI Cat 2 vs 1  1.519 (1.208-1.908) 
        Cat 3 vs 1      1.864 (1.421-2.446) 
       Cat 4 vs 1 1.485 (1.024-2.154) 
 
It should also be noted that point estimates for Health Disparity Indicator Score 
Categories for CVD morbidity among adults 30 years and older were higher for all adult 
participants (i.e., with and without hypertension) than for the hypertensive study 












Table 19.  
 
Odds Ratios with Point Estimates for Health Disparity Indicator Score Categories for 
CVD Morbidity Among Adults 30 Years and Older 




      (95% CL) 
Category 2 vs 1  2.210 (1.842-2.652) 
Category 3 vs 1      2.833 (2.242-3.580) 
Category 4 vs 1 3.201 (2.364-4.335) 
 
Research Question 2  
 
RQ2: What are the significant differences in CVD mortality outcomes between 
hypertensive subpopulations experiencing health disparities and the best group (i.e., the 
subpopulation with the best CVD mortality outcomes) in the United States for 
hypertension and when three or more of the following indicators intersect? (Health 
disparity indicators-age, gender, PIR, race/ethnicity, and education level).  
H02: There are no significant differences in CVD mortality outcomes between 
hypertensive subpopulations experiencing health disparities and the best group with 
hypertension in the United States when three or more indicators intersect was the null 
hypothesis that was rejected.  Multivariable analyses were conducted within and across 
the five disparity indicators to examine CVD mortality among participants with 
hypertension who are 30 years and older.  As indicated in Table 20, CVD mortality 
hazard ratios increased as: participants got older (i.e., the hazard ratio was 21.1 for 
participants who were 80+ years-old in comparison to 1.00 for those who were between 
the ages of 30-44 years); in males versus females; participants with incomes below the 
poverty level was 1.8 times more likely to report CVD mortality than those whose 
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income was above the poverty level; and in those participants who are Caucasian or 
White.  Participants were also less likely to experience CVD mortality as their education 
level increased.  Those with less than high school education were 3 times more likely to 
report CVD mortality in comparison to participants who were college graduates are 
above.     
Table 20.  
 
Hazard Ratios with Point Estimates for CVD Mortality Among Adults 30 Years and 
Older With Hypertension 
 Point Estimates Hazard Ratios 
Age   
30-44 years Comparison grp. 1.000 
45-54 years 0.6144 1.849 
55-64 years 0.9466 2.577 
66-74 years 1.7268 5.623 
75-79 years 2.1616 8.685 
80+ years 3.0521 21.16 
Sex   
Male Comparison grp. 1.000 
Female -0.3909 0.676 
Poverty-income ratio   
Income below poverty level 0.6067 1.834 
Income above poverty level Comparison grp. 1.000 
Race/ethnicity   
White Comparison grp. 1.000 
Black  -0.0869 0.917 
Hispanic -0.4001 0.670 
Other Race (Including Multi-racial) -0.4957 0.609 
Education level   
Less Than High School 1.1377 3.120 
High School Diploma 0.7089 2.032 
Some college or AA degree 0.6906 1.995 
College graduate or above Comparison grp. 1.000 
 
Interactions were assessed between disparity indicators by assigning Health 
Disparity Indicator Scores to the health disparity indicators. According to Table 21, there 
were significant differences in CVD mortality outcomes between hypertensive 
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subpopulations experiencing health disparities when three or more health disparity 
indicators intersect.   
Table 21.  
 
Odds Ratios with Point Estimates for Health Disparity Indicator Scores for CVD 
Mortality Among Adults 30 Years and Older With Hypertension 
Number of Health 
Disparity Indicators  
Pt. Estimates 
Odds Ratios 
(95% CL) Frequency Standard 
Error 
HDI Score=0  
Comparison 
grp. 
 82 0.281 




2 vs. 0 
9.512 (5.484-
16.498) 
2978    0.6664 
3 vs. 0 
12.192 (6.717-
22.129)       
2149    0.6339 
4 vs. 0 
13.771 (7.515-
25.235)       
1207    0.3421 
 
Health Disparity Indicator Score Categories were created to combine scores with 
small frequencies and large confidence intervals.  Category 1 contains 0 to 1 health 
disparity indicators, category 2 contains 2 health disparity indicators, category 3 contains 
3 health disparity indicators, and category 4 contains 4 to 5 health disparity indicators.  
Table 22 shows that the CVD mortality increases significantly as the number of health 
disparity indicators increase (i.e., hazard ratios were 1.59 and 2.44 for 3 and 4 or more 
health disparity indicators in comparison to 0 to 1 health disparity indicator).   There were 
significant differences in CVD mortality outcomes between hypertensive subpopulations 
who were 30 years and older experiencing health disparities when three or more 




Table 22.  
 
Health Disparity Indicator Score Categories with Hazard Ratios Among Adults 30 Years 
and Older With Hypertension 
Number of CVD Death 
Disparity Indicator Categories 
Point Estimates Standard Errors Hazard Ratios 
    
HDI Cat 1 0  1.000 
HDI Cat 2 vs Cat 1 0.4809  0.176 1.618 
HDI Cat 3 vs Cat 1 0.4636 0.252 1.590 
HDI Cat 4 vs Cat 1 0.8942 0.215   2.445 
 
Summary 
In summary, findings of this study indicated that there were significant 
differences in CVD morbidity outcomes between hypertensive subpopulations who were 
30 years and older experiencing health disparities when up to three health disparity 
indicators intersect in comparison to participants with 0 to 1 health disparity indicator.  It 
was also found that these significant differences in CVD morbidity outcomes also exist 
among all adults 30 years and older with and without hypertension when up to four health 
disparity indicators intersect in comparison to participants with 0 to 1 health disparity 
indicator.  Additionally, there were significant differences in CVD mortality outcomes 
between hypertensive subpopulations in the United States who were 30 years and older 
experiencing health disparities when three or more health disparity indicators intersect.  
Chapter 5 will discuss the interpretation of the findings, the limitations, the 
recommendations, and the implications of the study. 
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Chapter 5: Discussion, Conclusions, and Recommendations 
Introduction 
The purpose of this research was to investigate whether significant differences in 
CVD morbidity and/or mortality outcomes existed between persons with hypertension 
who experience three or more health disparities indicators and the best identified group 
with hypertension in the United States. I designed this cross-sectional quantitative study 
to determine the significance of the convergence of multiple indicators for health 
disparities (i.e. race, gender, education, income, and age) on the CVD outcomes of people 
with hypertension.  The research population consisted of NHANES participants with 
hypertension, ages 30 years and older, for the years 1999 to 2010.   
I assessed the descriptive statistics, bivariate analyses, multivariate analyses, odds 
ratios, hazard ratios, as well as interactions between health disparity indicators in the data 
analyses.  Independent variables were education level, age, poverty income ratio, highest 
education level completed, race/ethnicity, and gender.  The dependent variables were 
CVD morbidity and CVD mortality.  I performed this research study was to investigate 
whether the intersection of at least three of the independent variables had an impact on 
the prevalence of CVD morbidity and mortality among 1999 to 2010 NHANES 
participants with hypertension between the ages of 30 years and up.  I considered the 
impact of blood pressure medication.  I also identified those participants with 
hypertension who were taking prescribed medication to control their blood pressure.  Key 
findings from the data analysis showed that the following null hypotheses could be 
rejected.  First, there are no significant differences in cardiovascular disease morbidity 
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outcomes between hypertensive subpopulations experiencing health disparities and the 
best group in the United States for hypertension and when three or more indicators 
intersect. Second, there are no significant differences in cardiovascular disease mortality 
outcomes between hypertensive subpopulations experiencing health disparities and the 
best group in the United States for hypertension and when three or more indicators 
intersect. This means that NHANES 1999-2010 participants who were at least 30 years-
old with hypertension were more likely to be affected by CVD morbidity and mortality as 
a result of the cumulative effect of at least three health disparities indicators.   
Interpretation of Findings 
It is well-established in the literature that certain populations experience health 
disparities and are disproportionately impacted by CVD and hypertension. According to 
Duran and Perez-Stable (2019), there are research findings which “demonstrate that 
health disparities exist, even without poverty, and with high education and adequate 
access to care” (p. S8).  The emphasis of this study was on hypertension and its impact on 
certain populations.  According to the Institute of Medicine (IOM) in 2010, it was 
estimated that direct and indirect hypertension costs were 73.4 billion in 2009 alone.  
This research study extends the knowledge base.  My research found that there were 
significant differences in CVD morbidity and mortality outcomes between hypertensive 
subpopulations experiencing health disparities and the best group in the United States 
(i.e., the hypertensive subpopulations with 0-1 HDI) when three or more health 
disparities indicators intersect.  The impact of blood pressure must be considered 
alongside other risk factors.  This aligns with what was described in the literature review 
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(Ritchey, et al., 2014; Duran and Perez-Stable, 2019) and is reinforced in the findings of 
this research.  Education, age, gender, poverty income ratio, and race/ethnicity are the 
health disparities indicators that were used as independent variables.  There are also risk 
factors for hypertension that must be considered.  The following risk factors contributed 
substantially to the burden of hypertension: overweight and obesity, high sodium intake, 
unhealthy diet, and decreased physical activity (Institute of Medicine, 2010).   
Gender, age, education, race/ethnicity, and poverty-income ratio on the national 
level among adults are the health disparity indicators that were the foci of this research.  
Interventions and policies that are needed to eliminate these health disparities are far-
reaching and include social determinants of health that often exceed the resources and 
capabilities of public health.  Population-based policy interventions and interventions 
directed at systems-level improvements should be considered when seeking ways to 
prevent hypertension in the general population, as well as those who are 
disproportionately impacted.  In a report brief titled: A Population-based Policy and 
Systems Change Approach to Prevent and Control Hypertension, the Institute of 
Medicine (2010) suggests integrating hypertension prevention and control interventions 
into the policies and programs of public health practices in ways that ways that not only 
support healthy eating, active living, and obesity, but also  align their with populations 
who are most likely to be affected by hypertension.  These efforts should be multifaceted.  
According to Agurs-Collins, et al. (2019), the wide ranging and multi-faceted factors that 
cause health disparities comprise every level of the socioecological model.  From a 
research perspective, the National Institutes of Health has appealed for more research 
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utilizing a multi-level approach to address the health needs of disadvantaged populations 
(Agurs-Collins, et al., 2019).  This reinforces the theoretical basis of this research study.  
In the next section I describe the two research questions with the accompanying 
null hypotheses and alternative hypotheses.  I also discuss whether each of the alternative 
hypotheses were supported by my research findings. 
Research Question One 
RQ1: Are there significant differences in the selected CVD morbidity outcomes 
between hypertensive subpopulations, adults who are 30 years and older, experiencing 
health disparities and the best group (i.e., the subpopulation with the best CVD morbidity 
outcomes) in the United States for hypertension and when three or more indicators (race, 
gender, education, age and income) intersect?    
H01:  There are no significant differences in the selected CVD morbidity 
outcomes between hypertensive subpopulations experiencing health disparities and the 
best group with hypertension in the United States when three or more indicators intersect.   
 Ha2: There are significant differences in the selected CVD morbidity outcomes 
between hypertensive subpopulations experiencing health disparities and the best group 
with hypertension in the United States when three or more indicators intersect.  The 
results of this research study supported the alternative hypothesis for three or more health 
disparity indicators among people with hypertension 30 years or older. 
Many of the disparities that were discussed in the literature review were supported 
in the findings of my research.  The findings of the study showed that CVD morbidity 
increased as participants: got older; in males versus females; when incomes were below 
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the poverty level; among Blacks; and among those with less than high school education.  
This is confirmed by findings in the literature review that examined up to two health 
disparity indicators (Liao, et al., 2011; Liu, et al., 2011; Ritchey, et al., 2014).  This 
research study expands the knowledge base by examining the morbidity and mortality 
CVD outcomes that result from the intersection of three or more health disparity 
indicators.  There were significant differences in CVD morbidity outcomes between 
hypertensive subpopulations who were 30 years and older experiencing health disparities 
when three health disparity indicators intersect in comparison to participants with 0 to 1 
health disparity indicator.  In similar research study by Gupta (2014), the researcher 
examined multiple risk factors for CVD in Delaware using the BRFSS.  The researcher 
found that more persons with CVD reported multiple risk factors.  Additionally, the 
prevalence of multiple risk factors was higher for the aged, less educated, and 
unemployed (Gupta, 2014).   
Research Question Two 
RQ2: What are the significant differences in CVD mortality outcomes between 
hypertensive subpopulations experiencing health disparities and the best group (i.e., the 
subpopulation with the best CVD mortality outcomes) with hypertension in the United 
States when three or more indicators (race, gender, education, age and income) intersect?   
H02:  There are no significant differences in CVD mortality outcomes between 
hypertensive subpopulations experiencing health disparities and the best group with 
hypertension in the United States when three or more indicators intersect.  Ha2: There are 
significant differences in CVD mortality outcomes between hypertensive subpopulations 
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experiencing health disparities and the best group with hypertension in the United States 
when three or more indicators intersect.  The research study results found that the 
alternative hypothesis was correct for three health disparity indicators among persons 30 
years or older with hypertension. 
The likelihood of CVD mortality increased in the research study as: participants 
got older; in males; with incomes below the poverty level; in Whites; and among those 
with less than high school education.  This is consistent with the findings of Perez-Stable, 
(2019) in the literature review.  Regarding the CVD mortality outcomes, it must also be 
noted that Whites were found to be disproportionately impacted.  This differs with a 
study in the literature review that found higher mortality rates among hypertensive men 
than hypertensive women, and among hypertensive Blacks than hypertensive Whites 
(Ford, 2011).  However, the research finding in this study regarding Whites does relate to 
the finding in another study that CVD is a more common cause of death at older ages and 
that Whites were found to have a higher life expectancy in comparison to most other 
race/ethnic groups in the United States (Kochanek et al., 2015).   
  My research study found significant differences in CVD mortality outcomes 
between hypertensive subpopulations experiencing health disparities when three or more 
health disparity indicators intersect in comparison to 0 to 1 health disparity indicator.  I 
also found that the higher HDI groups were associated with worse CVD outcomes overall 
regardless of hypertensive status.  No comparison research was published in the literature 




Theoretical Framework: Systems Theory 
The findings of this research suggest that when three or more health disparity 
indicators intersect in persons with hypertension, then this may result in a cumulative 
effect that exacerbates CVD morbidity and mortality.  In addition to the impact of health 
disparities and the social determinants of health, Duran and Perez-Stables (2019) stated 
that developments in science suggest additional health determinants need to be 
considered in multilevel etiologic analyses to understand the contributors of health 
disparities.  According to Argur-Collins, et al., (2019), “the factors that underlie 
disparities are wide ranging and multifaceted; these factors encompass every 
socioecological level, including individual, interpersonal, community, and societal” (p. 
S86).  These multilevel interventions can be tailored to focus on specific subpopulations.  
For example, Timmons, et al. (2017) described a patient-centered intervention that aligns 
with Systems theory and the socioecological model which addresses hypertension-related 
health disparities.  The researchers identified three multilevel elements (i.e., social 
support, lifestyle coaching, and personalized medical management) that are believed to 
be critical components of interventions that can successfully manage hypertension in at-
risk Blacks. 
Limitations of the Study 
The NHANES survey was the source of the large data sample but such factors as 
selection bias and response rate may have impacted the research study outcomes. 
Limitations in areas such as generalizability, validity, trustworthiness, and reliability 
arose from my execution of this cross-sectional correlational study. Generalizability is 
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limited because this is a correlational study that in which causation cannot be assumed.  
My findings also cannot be generalized to noninstitutionalized populations.  I also have 
concerns regarding internal validity and trustworthiness because of the health interview 
portion of the data collection.  The health interview relies on the participant to remember 
specific events which subjects the study to recall bias.  Difficulty with memory among 
the participants was also a limitation.  Finally, data from the NHANES survey was 
collected during the years of 1999 to 2010 for this research study.  The age of the dataset 
is also a limitation that must be considered.   
I did not analyze the confounding variables such as smoking, obesity, and 
diabetes that may also influence CVD outcomes in this study.  As result, this may 
indicate the need for further research that includes these contributing factors.  
Additionally, the impact of taking hypertension medication must also be considered 
across the health disparity indicators.  When I compared taking hypertension medication 
across the health disparity indicators, there were no significant difference across them 
with 95% CIs, and 1.08, 1.00- and 1.06-Point Estimates for Health Disparity Indicator 
Categories vs. Taking Hypertension Medication.  
Recommendations for Study 
Findings from this research study showed that there were significant differences 
in CVD morbidity and mortality outcomes between hypertensive subpopulations 
experiencing health disparities and the best group in the United States for hypertension 
when three or more indicators intersect amongst 1999-2010 NHANES participants 30 
years and older.     
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I suggest the following recommendations as I considered the strengths and 
limitations of this research study based on the literature that I reviewed.  The principles of 
Systems theory can be applied to future interventions that are designed to eliminate the 
health inequities and address the social determinants of health that are associated with 
hypertension and CVD.  The theoretical framework that Systems theory provides should 
be used in future research to examine the relationships between different subareas of 
health disparities indicators related to hypertension and CVD.  The outcome of this 
research study suggests that more research and public health interventions are needed on 
issues related to hypertension and CVD among subpopulations who are impacted by 
multiple health disparity indicators (i.e., three or more) and risk factors.  Additional 
research that compares hypertension and CVD health outcomes of people with 
hypertension and non-hypertensives, as well as comparing those who take hypertension 
medication with those who do not take hypertension medication is needed.  Confounding 
variables such as smoking, obesity, and diabetes that may also influence CVD outcomes 
were not analyzed in this study.  As result, this may indicate the need for further research 
that includes these contributing factors. 
 
Implications for Positive Social Change 
The findings of my research study may have potential impact on hypertension and 
CVD morbidity and mortality outcomes through changes in clinical and public health 
practice by increasing the knowledge and awareness of providers, public health 
practitioners, and policymakers.   Healthcare practitioners and providers can utilize the 
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findings of this study to increase focus on those patients with multiple health disparity 
indicators.  Other changes in clinical practice may result in the use of clinical data and 
aggregate reports to pinpoint gaps in clinical care for patients (such as patients that are 
hiding in plain sight or patients that are diagnosed, but uncontrolled) and implement 
innovative activities to improve health outcomes among the patient population.  Public 
health practitioners could use the results of this research study to enhance surveillance 
and tailor interventions to serve persons with hypertension who are faced with multiple 
health disparity indicators.  Public health practice may be expanded to address the social 
determinants of health by directly impacting care such as medication coverage/costs, 
transportation to medical appointments, housing instability and food insecurity.   
Policymakers are also crucial to the needs of persons with hypertension.  They can 
develop and promote policies that address the multiple health disparities and social 
determinants of health that impact the health outcomes of persons with hypertension. If 
this is achieved, then this research may contribute to positive social change by 
contributing to the reduction of morbidity and mortality from CVD, decreasing the 
burden of hypertension, improving the quality of life, and impacting positive changes on 
multiple levels (i.e., individual, interpersonal, organizational, community, and public 
policy) of society.   
Systems theory was used as the theoretical basis which has implications when 
exploring the connections between multiple perspectives, components, and subareas on 
the macro level.  Its focus on the inter-relations of multiple perspectives from complex 
systems, multiple variables, as well as the ability to simultaneously explore these 
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connections between different components and subareas on the macro level is relevant.  
In their study outlining the skills needed and the challenges associated with multilevel 
interventions, Agurs-Collins et al., (2019) recommends that resources are directed to 
multilevel interventions that target the broader community, societal, and environmental 
contexts that produce greater reductions in health disparities versus approaches targeting 
a single level.  The findings from this research study may help to advance public health 
practice, generate new research, and influence clinical practice by contributing to the 
knowledge base in the areas of CVD and hypertension health inequities and health 
disparities.    
Conclusion 
In conclusion, I utilized a cross sectional quantitative study design to examine 
whether there were significant differences in the selected CVD morbidity and mortality 
outcomes between hypertensive subpopulations of adults who are 30 years and older, 
experiencing health disparities and the best group (i.e., the subpopulation with the best 
CVD morbidity outcomes) in the United States for hypertension and when three or more 
health disparity indicators (race, gender, education, age and income) intersect.  The 
findings showed that there were significant differences among people with hypertension 
in morbidity and mortality CVD outcomes when three or more health disparity indicators 
intersected.  Education, income, gender, poverty income ratio, and race/ethnicity are key 
health disparities indicators that intersect and must be considered when seeking ways to 
reduce hypertension and CVD inequities among persons 30 years and older who are at an 
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